Entries |
Document | Title | Date |
20080213225 | SULFUR-OXIDIZING PLANT GROWTH PROMOTING RHIZOBACTERIA FOR ENHANCED CANOLA PERFORMANCE - Described herein is the isolation and identification of a number of sulfur oxidizing plant growth promoting rhizobacteria: RAY12, identified as | 09-04-2008 |
20080213226 | COMPOSITIONS INCLUDING AMMONIA OXIDIZING BACTERIA AND METHODS OF USING SAME - A preparation and method for treating a subject how had developed or is at risk of developing at least one of high blood pressure, Alzheimer's Disease, obesity, and Diabetes Type II, Sickle Cell Anemia, Preeclampsia, Sudden Infant Death Syndrome, or Vascular disease comprising positioning ammonia oxidizing bacteria close proximity of a surface of the subject, of nitric oxide and nitric oxide precursors using ammonia oxidizing bacteria. | 09-04-2008 |
20080226603 | Prebiotic - Carbohydrates, in particular mannose containing carbohydrates, are used as a promotor of cell growth. Specifically, polysaccharide hydrolysates are shown to have superior efficacy in promoting the growth of cells, synbiotic foods, prebiotics and pharmaceutical compositions containing mannose containing carbohydrates and polysaccharide hydrolysates described. | 09-18-2008 |
20080241104 | ESPFU NUCLEIC ACIDS AND PROTEINS AND USES THEREOF - Disclosed are EspF | 10-02-2008 |
20080254000 | Methods of Improving the Yield and/or Quality of Aquatic or Marine Animals - Methods of treating aquatic or marine animal water bodies including contacting the water body with one or more sulfur oxidizing bacteria such as those selected from the genus | 10-16-2008 |
20080260695 | Composition for prevention and/or treatment of cancer - The invention relates to a composition for use in the prevention and treatment of cancer. The composition includes fermented soy extract, oligomeric proanthocyanidin, epigallocatiechin gallate, spirulina, curcumin and | 10-23-2008 |
20080260696 | Method for decreasing inflammation and oxidative stress in mammals - The present invention is directed to a method for decreasing inflammation and oxidative stress in a mammal comprising; administration to a mammal a composition comprising a glucose anti-metabolite; and wherein said composition comprises amounts of the glucose anti-metabolite sufficient to decrease a level of an oxidized glutathione and/or increase the ration of reduced glutathione to oxidized glutathione in the blood of the mammal subsequent to administration of the glucose anti-metabolite. | 10-23-2008 |
20080274085 | Probiotic Bifidobacterial Species - A probiotic composition comprising a | 11-06-2008 |
20080286240 | Ecologically Protected Material - The present invention relates to an ecological protected material, comprising a base material ( | 11-20-2008 |
20080311081 | Bacteria mediated gene silencing - Methods are described for the delivery of one or more small interfering RNAs (siRNAs) to a eukaryotic cell using a bacterium or BTP. Methods are also described for using this bacterium to regulate gene expression in eukaryotic cells using RNA interference, and methods for treating viral diseases and disorders. The bacterium or BTP includes one or more siRNAs or one or more DNA molecules encoding one or more siRNAs. Vectors are also described for use with the bacteria of the invention for causing RNA interference in eukaryotic cells. | 12-18-2008 |
20090004147 | Composition for a healthy gastrointestinal tract - The composition combines Zinc Carnosine; Beta Carotene; Vitamin A; Copper; Calcium Ascorbate; White Tea; Fructo-oligosaccharides; and Probiotic ( | 01-01-2009 |
20090004148 | Novel Probiotic - The present invention relates to a novel Gram positive species that has been isolated from the porcine intestine. The Gram positive bacterium of the invention has unprecedented properties that relate to its capacity to grow on a wide range of industrial feeds including oligosaccharide carbohydrates both in vitro and in vivo in animals. The Gram positive bacterium of the invention may be used alone as probiotic or in synbiotic combination with oligosaccharide carbohydrates. Specific applications include the promotion of health, growth performance and colonization resistance in monogastric animals. | 01-01-2009 |
20090010890 | STORAGE STABLE COMPOSITIONS OF BIOLOGICAL MATERIALS - Storage stable compositions of biological materials, including bioactive biological materials are provided in the form of a water-in-oil emulsion, comprising:
| 01-08-2009 |
20090010891 | Sepsis Treatment Agent - To provide a bacterial translocation preventive for humans and animals comprising a probiotics formulation which has lactic acid bacteria, butyric acid bacteria, and saccharifying bacteria as the main components thereof. And to provide a sepsis treatment agent for humans and animals comprising a probiotics formulation which has lactic acid bacteria, butyric acid bacteria, and saccharifying bacteria as the main components thereof. | 01-08-2009 |
20090010892 | Hyperlipidemia Treatment Agent - To provide a cholesterolemia treatment agent comprising, as an active ingredient, a bacterial mixture of three bacterial types consisting of lactic acid bacteria, butyric acid bacteria, and glycation bacteria which are effective in lowering serum cholesterol. And to provide a triglyceridemia treatment agent comprising, as an active ingredient, a bacterial mixture of three bacterial types consisting of lactic acid bacteria, butyric acid bacteria, and glycation bacteria which are effective in lowering triglycerides. | 01-08-2009 |
20090010893 | Canine probiotic Bifidobacteria globosum - According to the invention there is provided a strain of lactic acid bacteria of the species | 01-08-2009 |
20090022691 | BACTERIAL DELIVERY OF BIOLOGICALLY ACTIVE POLYPEPTIDES - The present invention relates to methods for the delivery of biologically active polypeptides to a subject by colonising non-pathogenic Gram negative bacteria. Also provided by this invention are methods of treating or preventing diseases by administering colonising Gram negative bacteria that express one or more biologically active polypeptides. The colonising non-pathogenic Gram negative bacteria may be administered in pharmaceutical formulations. | 01-22-2009 |
20090028826 | BACTERIAL EXTRACTS CULTURED IN THERMAL WATERS FOR REDUCING BAGS AND/OR DARK CIRCLES AROUND THE EYES - Bags and/or dark circles around the eyes of individuals afflicted therewith are reduced by administering to such individuals thus effective amounts of at least one extract of a non-photosynthetic and non-fruiting filamentous bacterium cultured in a medium which includes at least one non-sulfurous mineral and/or thermal water, e.g., an extract derived from the bacterium | 01-29-2009 |
20090041727 | Compositions and Methods for Microbe Storage and Delivery - The present invention relates to the field of bacteriology. In particular, the invention relates to compositions of probiotic microbes and methods for making and using such compositions, e.g. in the treatment and prevention of catheter associated urinary tract infections. | 02-12-2009 |
20090041728 | Proteoglycan Degrading Mutants for the Treatment of CNS - The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and their use for neurological functional recovery after central nervous system (“CNS”) injury or disease. | 02-12-2009 |
20090060876 | Orally Used Compatible Solutes Containing Agents - The invention relates to the use of compatible solutes, especially ectoine, hydroxyectoine, di-myo-inositol phosphate (DIP), cyclic 2,3 diphosphoglycerate (cDPG), 1,1-di-glycerol phosphate (DGP), β-mannosylglycerate (firoin), β-mannosylglyceramide (firoin A), proline betaine and/or derivatives as well as combinations thereof for the production of an agent aimed at preventing and treating gastrointestinal and amyloidal diseases, with agents containing said active ingredients being disclosed as well. | 03-05-2009 |
20090060877 | Use - Use of whole cells of bacteria from the genera of aerobic organisms in the order of Actinomycetales in the manufacture of a medicament for the treatment or prevention of Type II diabetes and/or obesity and methods of treating or preventing Type II diabetes and/or obesity in a subject by administering an effective amount of a composition comprising a whole cell of a bacterium from a genera of aerobic organisms in the order of Actinomycetales to said subject. Preferably the bacteria is from one or more of the following genera for example: | 03-05-2009 |
20090060878 | Oral Compositions, Products And Methods Of Use - The present invention comprises an oral composition. More particularly to a method of treating and preventing a respiratory tract infection and providing energy, relieving stress, and mood enhancing benefits to a human comprising: the steps of administering to a human a composition comprising from about 450 IU to about 500,000 IU of cholecalciferol, per dose of the composition. | 03-05-2009 |
20090060879 | Oral Compositions, Products and Methods Of Use - The present invention comprises an oral composition. More particularly to a method of treating and preventing a respiratory tract infection and providing energy, relieving stress, and mood enhancing benefits to a human comprising: the steps of administering to a human a composition comprising from about 450 IU to about 500,000 IU of cholecalciferol, per dose of the composition. | 03-05-2009 |
20090068150 | LACTIC ACID BACTERIA CULTURE OF MUNG BEAN AND THE PREPARATION METHOD OF THE SAME, AND THE COSMETIC COMPOSITION COMPRISING THE SAME - Disclosed is a lactic acid bacteria culture of mung bean obtained by culturing lactic acid bacteria in a culture medium containing mung bean extract. The culture contains the mung bean extract and GABA (ϝ | 03-12-2009 |
20090074725 | Live organism product - A live organism product wherein the organisms are in a dormant state and are suspended in a liquid carrier which is sufficiently devoid of moisture so that the organisms will remain in a dormant state for several months. The carrier is comprised of oil. The carrier may also include an absorbent. The product is stored and shipped in a plastic bag and is sprayed onto its target host or the like. The moisture and pH then activates the organisms. | 03-19-2009 |
20090081167 | FOLIC ACID PRODUCING BIFIDOBATERIUM BACTERIAL STRAINS, FORMULATIONS AND USE THEREOF - The present invention relates to folic acid-producing bacterial strains belonging to the genus | 03-26-2009 |
20090092585 | Canine probiotic bifidobacteria pseudolongum - According to the invention there is provided a strain of lactic acid bacteria of the species | 04-09-2009 |
20090098088 | Methods And Kits For The Treatment Of Diverticular Conditions - The present invention relates to methods and kits that are useful for the treatment of diverticular disease, diverticulitis, and combinations thereof. The methods comprise administering to a mammal in need of treatment a composition comprising a probiotic, either alone or in combination with an anti-inflammatory or an antibiotic. | 04-16-2009 |
20090110664 | PROBIOTIC COMPOSITIONS AND METHODS FOR INDUCING AND SUPPORTING WEIGHT LOSS - A probiotic composition for inducing or supporting weight loss in a subject, the probiotic composition including an effective amount of a bacteria selected from the genus | 04-30-2009 |
20090123429 | ARTHROSPIRA-BASED COMPOSITIONS AND USES THEREOF - The present invention concerns a composition comprising physiologically stressed | 05-14-2009 |
20090136454 | Anti-inflammatory activity from lactic acid bacteria - In the present invention, lactic acid bacteria produce soluble factors (such as peptides or proteins) that block inflammatory responses in a mechanism that depends on G proteins and is post-transcriptional to effectively block protein production or secretion by cells. | 05-28-2009 |
20090136455 | Canine probiotic bifidobacteria pseudolongum - According to the invention there is provided a strain of lactic acid bacteria of the species | 05-28-2009 |
20090142303 | METHODS AND COMPOSITIONS FOR DRIED CELLULAR FORMS - Methods and compositions of spray drying cellular material are provided that allow preservation of the cellular material. In one aspect, the cellular material is spray dried with a quantity of excipient. In another aspect, the cellular material is spray dried using a cryoprotectant. | 06-04-2009 |
20090142304 | Composition for Improving Intestinal Flora - A composition provided by the present invention for improving intestinal microflora includes 1-kestose as an active ingredient. The present invention further provides a lactic acid bacteria proliferating agent including 1-kestose as an active ingredient, which proliferates | 06-04-2009 |
20090148413 | Method for treatment of irritable bowel syndrome - A composition and method for treatment for bowel disorders is described. The composition consists of three parts. The first part is a highly purified, insoluble, chemically unmodified fiber from plants which is mixed with an aqueous solution such as water. The second part of the composition is a commercially available probiotic preparation. These commercially probiotic preparations contain large numbers of viable microorganisms of either | 06-11-2009 |
20090148414 | Novel Composition to Improve Gut Health and Animal Performance and Methods of Making the Same - The present invention relates to compositions comprising at least about 8% β-glucans and/or at least about 8% α-fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising β-glucans and/or α-fucans. | 06-11-2009 |
20090162322 | Oral administration form comprising probiotic bacteria - The invention relates to an oral administration form which comprises at least one species of probiotic microorganisms, where it itself and/or the probiotic bacteria is/are provided with a coating which comprises at least two cellulose ethers. | 06-25-2009 |
20090162323 | Method for Stimulating the Intestinal Flora - The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c) at least two different Bifidobacteria species, subspecies or strains for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. Thereby it is possible to stimulate the healthy development of the intestinal flora of said infants. | 06-25-2009 |
20090162324 | Use of Whole Cell Actinomycetales Bacteria to Treat Stress-Induced Pulmonary Haemorrhage - Use of whole cells of bacteria from the genera of aerobic organisms in the order of Actinomycetales in the manufacture of a medicament for the treatment or prevention of stress-induced pulmonary haemorrhage (SIPH), preferably exercise induced pulmonary haemorrhage (EIPH), and methods of treating or preventing SIPH, preferably EIPH, in a subject by administering an effective amount of a composition comprising a whole cell of a bacterium from a genera of aerobic organisms in the order of Actinomycetales to said subject. Preferably the aerobic organism is from one or more of the following genera for example: | 06-25-2009 |
20090169517 | Compositions and Methods for Tumor-Targeted Delivery of Effector Molecules - The present application discloses the preparation and use of attenuated tumor-targeted bacteria vectors for the delivery of one or more primary effector molecule(s) to the site of a solid tumor. The primary effector molecule(s) of the invention is used in the methods of the invention to treat a solid tumor cancer such as a carcinoma, melanoma, lymphoma, or sarcoma. The invention relates to the surprising discovery that effector molecules, which may be toxic when administered systemically to a host, can be delivered locally to tumors by attenuated tumor-targeted bacteria with reduced toxicity to the host. The application also discloses to the delivery of one or more optional effector molecule(s) (termed secondary effector molecules) which may be delivered by the attenuated tumor-targeted bacteria in conjunction with the primary effector molecule(s). | 07-02-2009 |
20090246177 | MEGASPHAERA ELSDENII STRAIN AND ITS USES - This invention relates to a novel strain of | 10-01-2009 |
20090252709 | NOVEL BACTERIUM BELONGING TO THE GENUS BIFIDOBACTERIUM AND UTILIZATION OF THE SAME - It is intended to provide | 10-08-2009 |
20090263356 | ANTI-ANGIOGENIC COMPOSITION COMPRISING GRAIN-DERIVED COMPONENT AS ACTIVE INGREDIENT - It is an object of the invention to provide a composition with an excellent action of inhibiting vascularization, as prepared by a simple method suitable for actual production from an inexpensive, relatively readily available material without any problematic safety profile at an industrial scale without any complicated purification step. The composition is a composition for inhibiting vascularization, which contains a barley-derived ingredient selected from the group consisting of an unpolished barley ethyl alcohol extract fraction, an unpolished barley alkali extract fraction and fermented barley (preferably, a residual solution from the distillation of barley distilled spirits) as the active component with an action of inhibiting vascularization. The composition for inhibiting vascularization is a composition for therapeutically treating or preventing diseases which vascularization should be inhibited, specifically diseases with an etiology of abnormal vascularization in tumor or cancer, chronic inflammation or retinopathy. The composition is in a form selected from the group consisting of food additives, food materials, foods and drinks, pharmaceutical products under regulations by the Ministry of Health and Labor in Japan and quasi-pharmaceutical products under regulations by the Ministry of Health and Labor in Japan, and feeds. | 10-22-2009 |
20090269307 | Edible Product Containing Ginseng Polysaccharides and Beneficial Bacteria - One aspect of the present invention relates to an edible product containing: • probiotic bacteria in an amount of at least 10 | 10-29-2009 |
20090274661 | USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION - The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of | 11-05-2009 |
20090274662 | Methods And Kits For The Treatment Of Inflammatory Bowel Disorder Conditions - The present invention comprises methods and kits that are useful for the treatment an inflammatory bowel disease. The methods comprise administering to a mammal in need of treatment a composition comprising an active agent in combination with a probiotic and/or optionally an antibiotic. | 11-05-2009 |
20090280091 | 5-FLUOROURACIL-RESISTANT BACTERIA AND METHOD FOR PRODUCTION THEREOF - The present invention provides a method for producing a cytosine deaminase (CD)-expressing, 5-fluorouracil (5-FU)-resistant microorganism which can grow in anaerobic tumor tissues, can express CD, and has a resistance to 5-FU at a concentration that is at least effective for antitumor activity. More specifically, the method is a method (A) comprising performing subculture or acclimation culture of a CD-expressing microorganism which can grow in anaerobic tumor tissues, in the presence of 5-fluorocytosine (5-FC), or a method (B) comprising (1) performing subculture or acclimation culture of a microorganism which can grow in anaerobic tumor tissues and does not express CD, in the presence of 5-FU to produce a 5-FU-resistant microorganism and (2) transforming the 5-FU-resistant microorganism by introducing a CD gene. The present invention also provides the CD-expressing, 5-FU-resistant microorganism and a pharmaceutical composition comprising the microorganism. | 11-12-2009 |
20090297482 | PROBIOTIC STRAIN AND ANTIMICROBIAL PEPTIDE DERIVED THEREFROM - The invention relates to a strain of | 12-03-2009 |
20090317363 | Cytokine Derivatives - The invention relates to polypeptides comprising an N-terminal portion and a C-terminal portion, wherein said N-terminal portion comprises the signature sequence QGP[P or L] and the amino acid sequence of said C-terminal portion is at least 70% identical to SEQ ID NO: 1, and uses thereof. | 12-24-2009 |
20090317364 | NOVEL COMPOSITIONS FOR PREVENTION AND TREATMENT OF MASTITIS AND METRITIS - A novel stable synergistic compositions used for the prevention and/or treatment of mastitis and metritis in mammals comprising a combination of therapeutically effective amount of | 12-24-2009 |
20090324551 | TLR AGONISTS - The present invention provides for TLR agonist conjugates (compounds) and compositions, as well as methods of using them. The compounds of the invention are broad-spectrum, long-lasting, and non-toxic combination of synthetic immunostimulatory agents, which are useful for activating the immune system of a mammal, preferably a human and can help direct the pharmacophore to the receptor within the endosomes of target cells and enhance the signal transduction induced by the pharmacophore. | 12-31-2009 |
20090324552 | CONTROLLED RELEASE CYTOTOXIC AGENT COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS - Disclosed herein are compositions and methods for the treatment of otic diseases or conditions with cytotoxic agent compositions and formulations administered locally to an individual afflicted with an otic disease or condition, through direct application of these compositions and formulations onto or via perfusion into the targeted auris structure(s). | 12-31-2009 |
20100015097 | METHOD OF MAKING SORBENT, THE SORBENT OBTAINED BY THIS METHOD AND THE USES OF THE SORBENT AS FEED ADDITIVE AND MEDICINE - The present invention relates to a method of making a sorbent, comprising the steeps of crushing seed husks, acid hydrolysis with extraction of water-soluble ballast substances and formation of the target composition of lignin, cellulose and melanin, water rinsing and drying, wherein the acid hydrolysis is made with an 0.1-36% acid solution during 0.3-4.5 hours in the boiling mode under pressure in the range 0.1-0.7 MPa, rinsing is made with water and/or a 0.1-1.0% alkali solution and then softened water, and the product is subsequently dried. The sorbent comprises a porous multilevel matrix on the basis of lignin, cellulose and melanin. The invention further discloses the sorbent and its uses as for prophylaxis and treatment of toxicoses, free-radical pathologies, diarrhea syndromes which are caused by ecotoxicants, viral and bacterial infections, for prophylactic and treatment of animal diseases caused by mycotoxins, pesticides, bad-quality forages in all kinds of animals. | 01-21-2010 |
20100055073 | TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDERS - An orally administrable nutritional formulation for use in the treatment of Pervasive Developmental Disorders (e.g. Autism, Asperger disorder or Retts disorder) contains free amino acids as the sole source of protein. The formulation may be administered to the patient as the sole daily source of protein or as a supplemental source of protein | 03-04-2010 |
20100074870 | Probiotic infant products - The present invention is directed to an infant formula or children's nutritional product comprising a protein source, a fat source, a carbohydrate source, and | 03-25-2010 |
20100074871 | Probiotic infant products - The present invention is directed to an infant formula or children's nutritional product comprising a protein source, a fat source, a carbohydrate source, and | 03-25-2010 |
20100074872 | COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING GASTROINTESTINAL, SKIN, AND NASAL MICROBIOTA - The present invention relates to characterizing changes in mammalian bacterial gastrointestinal, cutaneous and nasal microbiota associated with antibiotic treatment and various disease conditions (such as asthma, allergy, obesity, metabolic syndrome, gastrointestinal reflux disease (GERD), eosinophilic esophagitis, gastro-esophageal junction adenocarcinomas (GEJAC), infections due to bacteria that are resistant to antibiotics, including Methicillin-resistant | 03-25-2010 |
20100074873 | Live bacteria product - A live bacteria product including dormant viable bacteria suspended in a liquid carrier. The liquid carrier is sufficiently devoid of moisture so that substantially all of the bacteria will remain in a dormant state for several months or until applied to the target host. The liquid carrier has a moisture content of less than one percent and preferably has a moisture content of less than one-tenth of one percent. The carrier contains mineral oil and a suspension agent and may also include an adsorbent. The suspension agent may be polymers such as synthetic polymers. The product is stored and shipped in a plastic bag and is sprayed onto its target host or the like. The moisture and pH of the target host then activates the bacteria. | 03-25-2010 |
20100086521 | Means For Regulating The Cosmetic Appearance And/Or Health Of Human Keratinous Tissue - Regulating human keratinous tissue (e.g., skin, hair, and/or nails). More particularly, the invention relates to regulating the cosmetic appearance and/or health of human keratinous tissue by orally administering a dietary supplement comprising a probiotic to a human. In another aspect, the invention also relates to a method of marketing, an article of commerce, and a personal care kit. | 04-08-2010 |
20100092429 | Composition - The present invention provides a composition comprising: (a) one or more live | 04-15-2010 |
20100104536 | P38 INHIBITORS - The invention relates to novel p38 MAPK inhibitor which involves | 04-29-2010 |
20100119488 | PROBIOTICS TO IMPROVE GUT MICROBIOTA - The use of | 05-13-2010 |
20100129323 | Novel Shuttle Vector - The present invention provides a shuttle vector for a microorganism of the genus | 05-27-2010 |
20100129324 | BIOLOGICAL EFFECTS OF COMPOSITIONS COMPRISING ROSMARINIC ACID - The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject. | 05-27-2010 |
20100143307 | Use of Penicillin G Procaine as a selective antimicrobial agent in the production of alcohol by fermentation - A process for the use of low concentration levels of Penicillin G Procaine to eliminate or control the growth of unwanted or undesirable bacteria (contaminating bacteria) in the fermentation production of alcohol without inhibition of the growth or replication of the yeast. | 06-10-2010 |
20100150873 | NOVEL BACTERIA AND USES THEREOF - The present invention relates to a novel bacterium | 06-17-2010 |
20100150874 | PROBIOTICS TO REDUCE DEVELOPMENT OF ALLERGY IN INFANTS BORN BY CAESAREAN SECTION - The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for reducing the risk of subsequent development of allergy in infants delivered by caesarean section. | 06-17-2010 |
20100172874 | GUT MICROBIOME AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR AN OBESITY RELATED DISORDER - The present invention relates to the gut microbiome as a biomarker and therapeutic target for energy harvesting, weight loss or gain, and/or obesity in a subject. In particular, the invention provides methods of altering and monitoring the relative abundance of | 07-08-2010 |
20100172875 | OIL-IN-WATER EMULSION AND ITS USE FOR THE DELAYED RELEASE OF ACTIVE ELEMENTS - The present invention concerns the use of an oil-in-water emulsion where the interior of oil droplets exhibit interfaces, between lipophilic domains and hydrophilic or amphiphilic domains, due to the presence of a lipophilic additive solubilized inside the oil droplets and which is used for delayed release of active elements such that the release of at least one active element, which has a octanol/water partitioning coefficient logP higher than −1, corresponds to a higher Tmax than the Tmax obtained for the simple reference oil-in-water emulsion where no lipophilic additive is used. | 07-08-2010 |
20100172876 | PROTEIN FREE FORMULA - The invention relates to the use of composition comprising free amino acids as a sole source of protein, a fatty acid source comprising long chain polyunsaturated fatty acids, a carbohydrate source comprising digestible and indigestible carbohydrates, and milk protein free Bifidobacteria for treating a person suffering from (a) colic, congestion, runny nose, wheezing, vomiting, diarrhoea, bloody stools, mucus in stools, rash, eczema, gastroesophageal reflux, eosinophilic esophagitis or asthma; (b) cow's milk allergy and/or food protein intolerance; and/or (c) infections, wherein the indigestible carbohydrate is selected from a milk protein free source and the total composition is essentially free of intact proteins. | 07-08-2010 |
20100189693 | Novel Pasteuria Strain - The subject invention provides a novel and advantageous strain of | 07-29-2010 |
20100209394 | MITOGEN ACTIVATED PROTEIN KINASE MODULATOR - The present invention describes the method of modulating MAPK pathways. Further more the invention describes the use of Mycobacterium w for modulation of MAPK pathway intermediates for treatment of MAPK mediated conditions. | 08-19-2010 |
20100215620 | THE CO-CULTURE METHOD OF SPHINGOMONAS SP. BACTERIAL STRAIN AND ASPERGILLUS SP. FUNGUS STRAIN, NEW ANTI-CANCER AND ANTIBIOTIC GLIONITRINS DERIVED FROM THIS CO-CULTURE METHOD, AND PHARMACEUTICAL COMPOSITION CONTAINING GLIONITRINS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT - The present invention relates to a co-culture method of | 08-26-2010 |
20100221226 | Use of a Bifidobacterium Strain for Preparing a Composition for Preventing and/or Treating Allergic Manifestations - The present invention relates to the use of a | 09-02-2010 |
20100221227 | NOVEL METHOD OF TREATING DISEASE - This invention relates to compositions comprising a bacterium of the genus | 09-02-2010 |
20100233128 | Natural Skin Products Containing Dairy and Processes - A skincare product containing one or more dairy products, and one or more ingredients such as a natural oil, an herb, a fruit, a vegetable, a grain, honey, sea salt, egg yolk and mixtures thereof, for application to human skin in order to improve the well-being of said skin. The skincare product is applied to the skin in order to cleanse, beautify, promote attractiveness, and/or alter the feel or appearance of the skin. Furthermore, the skincare product is applied to the skin by rubbing, pouring, sprinkling, and/or spraying the skincare product onto the skin. | 09-16-2010 |
20100233129 | PREVENTION AND TREATMENT OF SECONDARY INFECTIONS FOLLOWING VIRAL INFECTION - This invention relates to a synthetic nutritional composition suitable for use in the prevention of secondary infections following a viral infection characterised by neuraminidase activity comprising a sialylated oligosaccharide and N-acetyl-lactosamine and/or an oligosaccharide containing N-acetyl-lactosamine The invention further extends to the use of such a composition in the prevention of secondary infections such as otitis media. | 09-16-2010 |
20100239537 | BACTERIAL ISOLATE AND METHODS FOR DETOXIFICATION OF TRICHOTHECENE MYCOTOXINS - The invention provides a bacterial isolate defined by accession number 180507-1 filed with the International Depository Authority of Canada. The bacteria are capable of degrading trichothecene mycotoxins. Also provided are compositions comprising the bacteria and methods of preventing or treating food, foodstuffs, crops and harvested crops that are contaminated or susceptible to contamination with trichothecene mycotoxins. Kits are also provided. | 09-23-2010 |
20100247489 | USE OF A COMPOSITION MADE OF MINERAL NUTRIENTS AND OPTIONALLY ACETOGENIC AND/OR BUTYROGENIC BACTERIA IN ORDER TO AVOID OR REDUCE THE FORMATION OF GAS IN THE LARGE INTESTINE OF A MAMMAL AND THE RESULTING ABDOMINAL PROBLEMS - The present invention relates to a composition comprising one or more minerals selected from the group consisting of selenium, molybdenum or tungsten, which is carried out galenically or chemically in a way that the mineral or minerals are released completely or in part, just before, during or shortly after arrival at the large intestine, and their use in the manufacture of a medicament for administering to a mammal for the prevention or reduction of gas formation in the colon thus conditioned abdominal complaints, particularly bloatings, meteorism or abdominal cramps. Furthermore, the invention relates to a procedure for the isolation of acetogenic and butyrogenic bacterial strains that are suitable for therapeutic purposes outlined above. | 09-30-2010 |
20100254948 | PROCESS FOR THE PREPARATION OF GAMMA-AMINO BUTYRIC ACID (GABA) BY THE USE OF LACTIC ACID BACTERIA (LAB) ON AGRO-AND FOOD-INDUSTRY SURPLUS - This invention relates to a process for the production of gamma-aminobutyric acid (GABA) from | 10-07-2010 |
20100254949 | PREBIOTIC OLIGOSACCHARIDES - The present invention provides galacto-oligosaccharide compositions that preferentially stimulate growth of specific | 10-07-2010 |
20100260720 | PREVENTION OF OPPORTUNISTIC INFECTIONS IN IMMUNE-COMPROMISED SUBJECTS - This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic | 10-14-2010 |
20100266550 | MAMMALIAN MILK MICROORGANISMS, COMPOSITIONS CONTAINING THEM AND THEIR USE FOR THE TREATMENT OF MASTITIS - The present invention relates to a novel approach to prevent or treat mastitis both in humans and animals through the use of mammal milk-derived microorganisms obtained from healthy hosts of the homologous species; to those new probiotic microorganisms obtained from milk able to reduce infectious mastitis and the method of screening used for their obtaining; to the use of these probiotic bacteria for the prophylaxis or treatment against mastitis and other diseases; and finally, to compositions comprising these compounds. | 10-21-2010 |
20100272689 | Protease Having Algicidal Activity, Gene Encoding the Same and Algicidal Formulation Comprising the Same - The present invention relates to a protease having algicidal activity, a gene encoding the same and algicidal formulation comprising the same. The protease according to the present invention showed high algicidal activity. Therefore, the protease can be used treatment of red tide in marine region of red tide occurrence. | 10-28-2010 |
20100278781 | NUTRITION WITH NON-VIABLE BIFIDOBACTERIUM AND NON-DIGESTIBLE OLIGOSACCHARIDE - An infant and/or toddler nutrition comprising non-viable | 11-04-2010 |
20100284973 | Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation - The present invention pertains to the field of prevention and treatment of chronic or acute diseases involving mast cells, such as allergy and some autoimmune diseases. More precisely, the present invention concerns the use of probiotics containing a | 11-11-2010 |
20100291038 | Novel Medicinal Formulation for Inducing an Immune Response in Patients with Chronic and Recurring Infections - A composition for the treatment of respiratory tract infection (RTI) comprising, a homogenized mixture of at least two serially diluted and potentized substances, as herein described, selected from: 1. | 11-18-2010 |
20100303763 | METHOD FOR DECREASING ABDOMINAL GIRTH BY ADMINISTERING A BIFIDOBACTERIUM BACTERIA - A method for decreasing abdominal girth in a subject by administering a probiotic, preferably a bacteria of the | 12-02-2010 |
20100310519 | Incorporation of Active Molecules into Microalga - Process of incorporating active and aggressive molecules into a microalga, with targeted recognition of cancer cells. The invention relates to the incorporation of active molecules into a microalga having first developed a plasmid, and/or a gene with resistance to the specific molecules. The process of the invention is particularly intended for human and veterinary medicine. | 12-09-2010 |
20100310520 | MICROORGANISMS FOR IMPROVING THE HEALTH OF INDIVIDUALS WITH DISORDERS RELATED TO GLUTEN INGESTION - The invention relates to microorganisms for the treatment of food allergies, specifically coeliac disease, as well as to methods for the selection thereof. The action mechanisms of said microorganisms include: (i) the regulation of the innate and adaptive immunological responses; (ii) the reduction of the concentration of toxic gluten peptide epitopes in the intestinal lumen; (iii) the strengthening of the barrier defence function against harmful antigens and bacteria; and (iv) the provision of enzymatic activities that promote digestion. | 12-09-2010 |
20100322904 | COMPOSITION COMPRISING BIFIDOBACTERIUM INFANTIS AND FRUCTO- AND GALACTO-OLIGOSACCHARIDES FOR THE PREVENTION OF INTESTINAL DISCOMFORT IN INFANTS - Compositions comprising bifidobacteria and galactooligosaccharides and fructooligosaccharides are provided that support the introduction of solid weaning foods in the diet of infants that receive infant milk formula or breast milk. | 12-23-2010 |
20110002891 | PROBIOTIC COMPOSITIONS AND PROCESS THEREOF - Probiotic composition(s) and/or process(es) thereof. Processes may include applying | 01-06-2011 |
20110008291 | Use of antifungal compositions to treat upper gastrointestinal conditions - The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms. | 01-13-2011 |
20110008292 | LACTOBACILLUS ACIDOPHILUS NUCLEIC ACIDS ENCODING FRUCTO-OLIGOSACCHARIDE UTILIZATION COMPOUNDS AND USES THEREOF - Fructooligosaccharide (FOS)-related protein nucleic acid molecules and polypeptides and fragments and variants thereof are disclosed in the current invention. In addition, FOS-related fusion proteins, antigenic peptides, and anti-FOS-related antibodies are encompassed. The invention also provides recombinant expression vectors containing a nucleic acid molecule of the invention and host cells into which the expression vectors have been introduced. Methods for producing the polypeptides of the invention and methods for their use are further disclosed. | 01-13-2011 |
20110014156 | Bifidobacterium for dust mite allergy - A composition comprising | 01-20-2011 |
20110020284 | PROBIOTIC BIFIDOBACTERIUM STRAINS - strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease. | 01-27-2011 |
20110020285 | Composition Containing Cacao and Spirulina - The invention relates to a composition containing | 01-27-2011 |
20110027232 | Formulations of viable microorganisms and their methods of production and use - The present invention relates to formulations of viable microorganisms in a water insoluble, water-absorbent substance and methods of producing formulations of viable microorganisms. Also disclosed is a method of treating plants and/or plant seeds with the formulations of the present application. | 02-03-2011 |
20110027233 | Prothioconazole Tolerant Cryptococcus Flavescens Strains for Biological Control of Fusarium Head Blight - Strains of | 02-03-2011 |
20110044951 | COMPOSITIONS FOR PREPARING A COFFEE BEVERAGE COMPRISING HYDROLYSED CHLOROGENIC ACID - The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage. | 02-24-2011 |
20110052538 | PROBIOTIC/NON-PROBIOTIC COMBINATIONS - This invention pertains to a method of promoting gastrointestinal health by ingesting a composition comprising one or more probiotic microorganisms, one or more carbohydrate sources, and one or more resistant protein products. Large intestinal health is benefited by one or more of the following: increased fecal weight, lower fecal pH, increased carbohydrate fermentation, and amelioration of protein fermentation. | 03-03-2011 |
20110081319 | COMPOSITION AND USE OF PHYTO-PERCOLATE FOR TREATMENT OF DISEASE - This invention relates generally to a method of preparation of a phyto-percolate that is derived from fresh water mixture including algae. The phyto-percolate is believed to contain an enzyme having proteolytic activity. The invention further relates to the use of the phyto-percolate in a variety of disease state. | 04-07-2011 |
20110081320 | Treatment/Cure of Autoimmune Disease - An embodiment entails administering an effective amount of a product such as a protease or a source of a protease that destroys or deactivates an immunogen, mimic or antigen specific to a particular autoimmune disease before it encounters the immune system of a patient. | 04-07-2011 |
20110097307 | Compositions and Methods for Augmenting Kidney Function - The present invention provides a nutritional food product composed of a prebiotic and an isolated protein for use in reducing elevated levels of nitrogenous waste products in the blood and ameliorating renal failure. | 04-28-2011 |
20110135608 | USE OF PROBIOTIC BACTERIA FOR THE TREATMENT OF HYPERHOMOCYSTEINAEMIA - The present invention refers to the use of probiotic bacteria for the treatment of hyperhomocysteinaemia. The present invention furthermore refers to a composition comprising probiotic bacteria in association with at least one vitamin chosen from the group comprising the B group of vitamins for the treatment of plasma hyperhomocysteinaemia. | 06-09-2011 |
20110158949 | Metabolically active micro organisms and methods for their production - The invention relates to a preparation of metabolically active bacteria, compositions comprising such a preparation, e.g., probiotic supplements or animal feeds, and to uses thereof, for example in the treatment of diseases affecting the intestinal microbial balance. Also described are a growth substrate for microorganisms comprising a mixture of complex and simple sugars and a process for the manufacture of preparations of metabolically active microorganisms using this growth substrate. | 06-30-2011 |
20110158950 | USE OF BLOOD GROUP STATUS I - Provided is a probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with non-secretor blood group phenotype. Further provided is a method of tailoring a probiotic composition based on the bifidobacteria found from the intestine of at least one non-secretor individual. | 06-30-2011 |
20110158951 | USE OF BLOOD GROUP STATUS II - Provided is a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. Further provided is a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | 06-30-2011 |
20110177034 | PROBIOTIC BIFIDOBACTERIUM LONGUM - The invention relates to novel, probiotic, anti-inflammatory strains of | 07-21-2011 |
20110177035 | USE OF SECRETOR, LEWIS AND SIALYL ANTIGEN LEVELS IN CLINICAL SAMPLES AS PREDICTORS OF RISK FOR DISEASE - An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewis | 07-21-2011 |
20110177036 | WHOLE BLOOD CULTURES COMPRISING STIMULATED IMMUNE CELLS, AND USE THEREOF AS MEDICAMENTS - The present invention relates to a whole-blood culture containing specific immunocompetent killer cells that are activated against tumor cells, viruses, bacteria and/or allergens, whereby the whole-blood culture consists of whole-blood and a culture medium at a ratio of 3:1 to 4:1, whereby the culture medium has an oxygen excess of at least 100% or more and contains a water-soluble emulsification product comprising a mixture of phospholipids, vitamin E, and low-molecular proteoglycans with a molecular weight of 1,200 to 12,000 Dalton, and whereby dead tumor cells or fragments thereof and/or viral and/or bacterial antigens and/or allergens have been added to the whole-blood culture [to serve] as antigen in the specific recognition process for production of the activated killer cells (stimulation). The invention also relates to a method for producing the culture, as well as stimulants for the whole-blood culture and a method for the selection thereof. | 07-21-2011 |
20110189133 | SKIN TREATMENT COMPOSITIONS - This invention relates to | 08-04-2011 |
20110189134 | FERMENTATION PRODUCT CONTAINING EQUOL-PRODUCING MICROORGANISM HAVING MAINTAINED EQUOL-PRODUCING ABILITY, AND METHOD FOR PRODUCING SAME - An object of the present invention is to provide a fermented product containing equol-producing microorganisms in the state of living cells by which equol production ability is maintained. | 08-04-2011 |
20110195051 | USE OF BACTERIA OF THE GENUS TENACIBACULUM FOR QUORUM QUENCHING - Use of bacterial cells of the genus | 08-11-2011 |
20110206641 | STRESS TOLERANT BIFIDOBACTERIA - The present invention relates in general to the field of Bifidobacteria. In particular the present invention relates to the field of Bifidobacteria with a modulated stress resistance. One embodiment of the present invention is a | 08-25-2011 |
20110206642 | Preventing obesity-related metabolic syndrome with melagonesis - Anti-inflammatory effect of α-MSH-like compounds can be employed for curtailing sequelae of obesity and overweight. Importantly, molecular compounds that stimulate melanin biosynthesis by mimicking the effects of α-MSH are readily available for trials aimed at control of metabolic syndrome components. Synthetic agonists of α-MSH receptors, melanotan II and bremelanotide, have already been proven safe in human trials for therapeutic tanning and some non-obesity-related diseases. | 08-25-2011 |
20110236354 | Symbiotic bacterial oncolysis-a beacon-based method for enhanced destruction of solid tumors-including both the tumor core and rim - Symbiotic bacterial oncolysis is a method to directly lyse and/or otherwise destroy the tumor core and rim of solid tumors using two (or more) phases of treatment. The first phase localizes with specificity for features of tumor microenvironment. The second (and/or subsequent) phase(s)—otherwise known as the SYMBIOT—localizes with specificity for features—designed, selected or inherent—of an earlier treatment phase (typically the phase 1). This earlier phase (typically phase 1) acts as a BEACON to help improve the specificity and/or localization of the subsequent—SYMBIOT—phases of treatment. Overall this should lead to improved solid tumor destruction relative to current art. | 09-29-2011 |
20110262400 | PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH - This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal. | 10-27-2011 |
20110268703 | PROBIOTIC STRAIN AND ANTIMICROBIAL PEPTIDE DERIVED THEREFROM - A strain of | 11-03-2011 |
20110268704 | ENHANCED SHELF LIFE AND ON SEED STABILIZATION OF LIQUID BACTERIUM INOCULANTS - The present invention includes a method for producing a liquid inoculant containing a desiccant. The method can improve survival and stability of bacteria in liquid inoculants in pack and on seeds. The method includes providing a liquid inoculant of a bacteria grown to a substantially stationary phase. A desiccant treatment containing a desiccant is added to the liquid inoculant to form a partially desiccated inoculant product. The partially desiccated inoculant product can be packaged and stored. The partially desiccated inoculant product can also be applied to seeds. | 11-03-2011 |
20110280840 | COMPOSITIONS AND METHODS FOR TREATING OBESITY AND RELATED DISORDERS BY CHARACTERIZING AND RESTORING MAMMALIAN BACTERIAL MICROBIOTA - The present invention relates to characterizing changes in mammalian gastrointestinal microbiota associated with antibiotic treatment and various disease conditions (such as obesity, metabolic syndrome, insulin-deficiency or insulin-resistance related disorders, glucose intolerance, diabetes, non-alcoholic fatty liver, abnormal lipid metabolism, short stature, osteoporosis, and other disorders of bone formation and mineralization, etc.) and related diagnostic and therapeutic methods. Therapeutic methods of the invention involve the use of probiotics, prebiotics, or narrow spectrum antibiotics/anti-bacterial agents that are capable of restoring healthy mammalian bacterial gastrointestinal microbiota. | 11-17-2011 |
20110293570 | ISOLATION OF NOVEL BACTERIA CONTRIBUTING TO SOILBORNE DISEASE SUPPRESSION - Embodiments relate to plant disease suppressive microorganisms and compositions including the same, methods for isolating disease suppressive microorganisms, and methods for controlling plant diseases using disclosed compositions and microorganisms. | 12-01-2011 |
20110300109 | COMPOSITIONS AND METHODS FOR TREATING CANCER - The present invention is based, in part, on our discovery of compositions and methods that can be used to systemically deplete arginine and thereby treat arginine-dependent cancers. Our studies indicate that administering a composition that depletes arginine directly to the patient's small intestine will provide effective treatment for arginine-dependent cancers. Moreover, the methods can be carried out in such a way that various sources of arginine are restricted and side effects are minimized. For example, to deplete arginine, one can not only administer an arginine-depleting enzyme directly to the intestinal lumen but can also inhibit endogenous production of arginine, reduce arginine production by intestinal bacteria and limit arginine intake. To minimize side effects, one can inhibit protein breakdown, which may occur as a compensatory mechanism, provide systemic NO from a nitric oxide donor, provide a pressor peptide, and/or provide prostacycline or an analog thereof. | 12-08-2011 |
20110300110 | ENAMINOCARBONYL COMPOUND/BENEFICIAL ORGANISM COMBINATIONS - The novel combinations of enaminocarbonyl compounds and beneficial species comprising, firstly, at least one enaminocarbonyl compound of the formula (I) | 12-08-2011 |
20110318309 | EQUOL-PRODUCING BACTERIUM AND USE THEREOF - The present invention is directed to a microorganism having an ability of converting daidzein to equol in 24 hours of 50% or higher; a food/beverage or pharmaceutical composition containing the microorganism; an equol production method employing the microorganism; and a nucleic acid fragment which can specifically detect the microorganism. | 12-29-2011 |
20110318310 | METHOD FOR ENHANCING STEM CELL TRAFFICKING - Consumption of blue-green algae, or extracts thereof, enhances trafficking or homing of stem cells in animals by inducing a transient increase in the population of stem cells present in the animal's circulatory system. The animal may be healthy or suffering some disease or physiological condition. | 12-29-2011 |
20120014923 | HYPOGLYCEMIC EFFECT ENHANCER - A hypoglycemic effect enhancer for enhancing the activity of an α-glucosidase inhibitor, the enhancer comprising at least one kind of bacteria selected from the group consisting of bifidobacteria, lactic acid bacteria, saccharifying bacteria, and butyric acid bacteria. | 01-19-2012 |
20120020926 | COMPOSITION COMPRISING CAFTARIC ACID AND/OR DERIVATIVES THEREOF - The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing caftaric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid. | 01-26-2012 |
20120020927 | Bacterial Strains Having an Outstanding Ability to Produce Menaquinone - The invention relates to bacterial strains having an outstanding ability to produce menaquinone and to applications thereof. | 01-26-2012 |
20120039853 | CRYOPROTECTANTS FOR FREEZE DRYING OF LACTIC ACID BACTERIA - The present invention comprises the discovery and development of an effective cryoprotectant composition, without containing skim milk or any other animal-derived compounds, to achieve long-term stability of freeze-dried lactic acid bacteria (LAB), at different temperatures, whereby the retention of viability of the freeze-dried LAB after 6 months of storage, preferably after 9 months of storage, more preferably after 12 months of storage is more than 50%. The invention is in the field of producing freeze dried bacteria, in particular Lactic acid bacteria. More in particular, the invention relates to the use of a novel combination of cryoprotectants for increasing the viability of bacteria after freeze drying, improving the texture of the lyofilized cake for easy grinding and improving the long term stability of the freeze dried bacteria at different temperature conditions. The invention further relates to such freeze dried bacteria for use in food industry or in human or animal health applications. More in particular, the invention relates to the increased viability and long-term storage of recombinant bacteria capable of expressing heterologous proteins or peptides and administered to humans or animals for therapeutic or vaccination purposes. | 02-16-2012 |
20120058087 | DIAGNOSIS OF ENDOMETRITIS - The present invention relates to methods for diagnosing and treatment of a dormant infection of at least one pathogen. The invention further relates to a composition comprising an anti-dormancy factor as well as to said composition for use in a method of diagnosis or treatment and also to a method for manufacturing said composition. The invention further relates to a kit of parts comprising, inter alia, said composition. The invention also relates to a method for activating a dormant infection. | 03-08-2012 |
20120064039 | Use of Guanylyl Cyclase C Agonists to Suppress Appetite - Compositions comprising a guanylyl cyclase C agonist formulated for sustained specific release of an amount effective to suppress appetite when administered orally to an individual are disclosed. Compositions comprising a guanylyl cyclase C agonist formulated for intravenous delivery in an amount effective to suppress appetite when administered intravenously to an individual are also disclosed. Methods of suppressing appetite in an individual are disclosed. | 03-15-2012 |
20120087895 | Probiotic Therapies for Autism - Provided is a method and a composition for improving behavioral performance in an individual comprising identifying an individual in need of treatment, and providing such an individual a composition comprising bacteria within the genus | 04-12-2012 |
20120087896 | HYDROXYLATED 1,2,4-OXADIAZOLE BENZOIC ACID COMPOUNDS, COMPOSITIONS THEREOF AND THEIR USE IN BIOASSAYS - Novel hydroxylated 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising a hydroxylated 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. | 04-12-2012 |
20120107279 | PREVENTION AND TREATMENT OF ROTAVIRUS DIARRHOEA - This invention relates to | 05-03-2012 |
20120107280 | BIOFUNGICIDAL COMPOSITION FOR CONTROLLING PHYTOPATHOGENIC FUNGI - Biofungicide composition derived from a biologically pure culture of a Chilean bacterial isolate obtained from the skin of grapes, corresponding to | 05-03-2012 |
20120128633 | USE OF COLLINSELLA AEROFACIENS FOR REDUCING BLOATING - The invention relates to compositions comprising | 05-24-2012 |
20120128634 | USE OF COLLINSELLA AEROFACIENS FOR REDUCING BLOATING - The invention relates to compositions comprising | 05-24-2012 |
20120141423 | NOVEL PAENIBACILLUS POLYMYXA STRAIN, ANTIBIOTIC ANTIMICROBIAL AGENTS AND METHODS OF THEIR USE - The present invention relates to a novel | 06-07-2012 |
20120156172 | NEW LACTIC ACID BACTERIA HAVING ITS INHIBITORY EFFECT ON AVIAN INFLUENZA VIRUS INFECTION AND COMPOSITION CONTAINING THE SAME - The present invention relates to a new microorganism | 06-21-2012 |
20120164109 | NUTRITIONAL COMPOSITION COMPRISING BIFIDOBACTERIUM LONGUM STRAINS AND REDUCING FOOD ALLERGY SYMPTOMS, ESPECIALLY IN INFANTS AND CHILDREN - A complete nutritional composition comprising | 06-28-2012 |
20120171163 | METHOD FOR INHIBITING A BACTERIAL INVASIVE MECHANISM USING A NUTRITIONAL COMPOSITION - A method for inhibiting a bacterial invasive mechanism involving administering to a human a nutritional composition including a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; about 0.1 to about 1 g/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide; at least about 10 mg/100 kCal of lactoferrin selected from the group consisting of non-human lactoferrin, human lactoferrin produced by a genetically modified organism, and combinations thereof. | 07-05-2012 |
20120171164 | USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS - The present disclosure relates to the use of nutritional compositions including lactoferrin in supporting resistance to a viral respiratory tract infection. The method includes administering to a human a nutritional composition comprising a fat or lipid source, a protein source and lactoferrin produced by a non-human source. | 07-05-2012 |
20120171165 | HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL BACTERIA - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 07-05-2012 |
20120171166 | SYNBIOTIC COMBINATION OF PROBIOTIC AND HUMAN MILK OLIGOSACCHARIDES TO PROMOTE GROWTH OF BENEFICIAL MICROBIOTA - Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial microbiota. Suitable additional methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed. | 07-05-2012 |
20120171167 | ANTI-OBESITY AGENT, ANTI-OBESITY FOOD OR BEVERAGE, GLUCOSE TOLERANCE-AMELIORATING AGENT, AND FOOD OR BEVERAGE FOR AMELIORATION OF GLUCOSE TOLERANCE - An anti-obesity agent or a glucose tolerance-ameliorating agent containing a bacterium belonging to the genus | 07-05-2012 |
20120177606 | LACTIC ACID BACTERIUM FOR INHIBITING PRODUCTION OF GASTRIC ACID AND GASTRIN - The present invention relates to a method of reducing the acid concentration within gastric fluid, suppressing a tendency towards a strongly acidic pH within the gastric fluid, and inhibiting the production of gastrin, by administering lived or killed lactic acid bacterium (such as | 07-12-2012 |
20120177607 | OXIDATIVE STRESS RESISTANT BIFIDOBACTERIA - The present invention relates in general to the field of Bifidobacteria. In particular the present invention relates to the field of Bifidobacteria with an improved resistance to oxidative stress. The inventors have identified a Bifido bacterium that exhibits for example an improved H | 07-12-2012 |
20120183506 | PREVENTION AND TREATMENT OF ALLERGIC DIARRHOEA - This invention relates to | 07-19-2012 |
20120201785 | USE OF BIFIDOBACTERIUM LONGUM FOR THE PREVENTION AND TREATMENT OF INFLAMMATION - The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of | 08-09-2012 |
20120207713 | PROBIOTIC BIFIDOBACTERIUM STRAINS - strain AH1206 or mutants or variants thereof are immunomodulatory following oral consumption and are useful in the prophylaxis and/or treatment of inflammatory activity for example undesirable gastrointestinal inflammatory activity such as inflammatory bowel disease. | 08-16-2012 |
20120213739 | METHOD TO GROW LAWSONIA INTRACELLULARIS BACTERIA IN PERSISTENTLY INFECTED MCCOY CELLS - The present invention pertains to a method to obtain McCoy cells persistently infected with | 08-23-2012 |
20120219527 | COMPOSITIONS FOR REDUCING GASTRO-INTESTINAL METHANOGENESIS IN RUMINANTS - The present invention concerns the reduction of gastro-intestinal methanogenesis in ruminants with the aid of agents that compete for the hydrogen atoms required by methanogens during normal fermentation of ingested feed. The invention in one aspect resides in the findings that both nitrate reductive pathways as well as sulphate reductive pathways outcompete gastro-intestinal methanogenesis in ruminants and, that the methanogenesis reducing effects of nitrate and sulphate are completely additive. At the same time the combined administration of nitrate and sulphate was found to be fully effective to avoid or mitigate the potential problems of nitrite intoxication normally encountered when using nitrate alone, which effect is further enhanced, where necessary, by the addition of a nitrite reducing probiotic micoroorganism. Hence, products are provided comprising high amounts of a combination of a nitrate compound and a sulphate compound and optionally a nitrite reducing probiotic microorganism, as well as methods of reducing gastro-intestinal methanogenesis in ruminants using such compositions. | 08-30-2012 |
20120225037 | Sporulation-Deficient B. texasporus Cells and Methods for Efficient and Cost-effective Inactivation and Use Thereof - Novel strains and methods for their use are provided. Particularly, foods and other oral products or treatments containing sporulation-deficient | 09-06-2012 |
20120230955 | ARABINOXYLANS FOR MODULATING THE BARRIER FUNCTION OF THE INTESTINAL SURFACE - The present invention is directed to a particular arabinoxylan (“AX”) preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium. Thus, in a further aspect the present invention provides compositions, both pharmaceutical and nutritional compositions, comprising said arabinoxylan preparations; in particular pharmaceuticals, medical foods, food supplements or food compositions, such as infant formula products, dairy products, bakery products or pastry products. The compositions optionally comprise probiotics such as | 09-13-2012 |
20120230956 | BIFIDOBACTERIUM LONGUM AND FUNCTIONAL GI DISORDERS - The present invention generally relates to the field of probiotic bacteria. In particular it relates to | 09-13-2012 |
20120230957 | COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN - The present invention provides compositions and methods for treatment or prevention of pain resulting from infection, infection related pain, and non-infectious pain as well as treatment or prevention of infections or adverse health consequences associated with infections. | 09-13-2012 |
20120237482 | METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS BY MODULATION OF MICROGLIAL ACTIVATION - Methods for treatment of neurological disorders with respect to microglial activation are presented herein. Other examples and related pharmaceutical combinations and compositions are also described herein. | 09-20-2012 |
20120251500 | Anti-Aging Formulations - A dietary supplement based on blue green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside IV, vitamin D3, vitamin C, anhydrous trimethylglycine and brewer's yeast to stimulate stem cell production and reduce the rate of telomere reduction or shortening. This can result in the repair of existing body cells and enhance longevity by stimulating the production of new stem cells and maintaining the telomeres on new stem cells as well as existing cells. The dietary supplement supports an increased life span by enhancing metabolic function, activating SIRT-1 anti-aging genes, and encouraging the production of new cells with longer telomeres. | 10-04-2012 |
20120251501 | Formulations for Promoting Stem Cell Nutrition - A a multivitamin and mineral dietary supplement includes a base composition of whole aphanizomenon flos-aqua, phycocyanin and phenylethylamine for promoting the body's natural production of stem cells. The production, support and maintenance of these stem cells is enhanced with vitamins and/or minerals. The vitamins and minerals when combined with the base composition promote good health, body repair and longevity. | 10-04-2012 |
20120276056 | Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine - The present invention relates to method of treating distal gastrointestinal diseases including infections, inflammations and functional motility disorders by oral administration of therapeutic or preventive biologic agent that is released directly to the disease area in the distal ileum, ileacecal junction or colon. The biologic agent may include live or dormant bacteria or other organism, e.g. yeast, or other biologic agent. The delivery vehicle must prevent release of the biologic agent in the upper segments of the gastrointestinal tract where it may lose its potency or decrease in quantity. | 11-01-2012 |
20120276057 | NUTRITIONAL COMPOSITION FOR SUPPORTING BRAIN DEVELOPMENT AND FUNCTION OF TODDLERS - The present invention relates to a nutritional composition, in particular directed to toddlers and/or a weaning child, said nutritional composition comprising a protein source, a source of available carbohydrates, a lipid source, at least one probiotic microorganism, and prebiotics, wherein said lipid source comprises DHA (docosahexaenoic acid). The nutritional composition improves cognitive performance, in particular learning and memory of the child. Preferably, the composition comprises sphingomyelin, sialic acid, choline, essential fatty acids and taurine. | 11-01-2012 |
20120276058 | METHANE REDUCING STRAINS AND METHODS OF USE - Strains and compositions of bacterium of the genus | 11-01-2012 |
20120276059 | FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR MONITORING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE - disease involves a range of clinical presentations ranging from mild to self-limiting diarrhea to life-threatening pseudomembranous colitis and megacolon. Cases of | 11-01-2012 |
20120276060 | FECAL LACTOFERRIN AS A BIOMARKER FOR DETERMINING DISEASE SEVERITY AND FOR TREATING INFECTION IN PATIENTS WITH CLOSTRIDIUM DIFFICILE DISEASE - disease involves a range of clinical presentations ranging from mild to self-limiting diarrhea to life-threatening pseudomembranous colitis and megacolon. Cases of | 11-01-2012 |
20120301435 | PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS - The present invention relates to a microbial or probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals of non-secretor blood group phenotype. The present invention further relates to a method of tailoring a microbial or probiotic composition based on the bifidobacteria found in the intestine of at least one individual with secretor blood group phenotype but not commonly found in individuals non-secretor blood group phenotype. | 11-29-2012 |
20120308525 | NUTRITIONAL COMPOSITIONS INCLUDING A HIGH PROTEIN COMPONENT AND EXOGENOUS NUCLEOTIDES - Nutritional compositions and methods of making and using the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including a high protein component and one or more exogenous nucleotides. The nutritional compositions can be specifically used to accelerate and improve wound healing in a mammal. | 12-06-2012 |
20120308526 | Sonic Low Pressure Spray Drying - This invention provides methods of spray drying pharmaceutical powders from a vibrating nozzle at low pressures. The method can effectively spray dry thick or viscous solutions or suspensions to provide small uniform particles. The invention includes dry particle compositions prepared by methods of low pressure spraying from vibrating nozzles. | 12-06-2012 |
20120308527 | PREVENTION OF OPPORTUNISTIC INFECTIONS IN IMMUNE-COMPRISED SUBJECTS - This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic | 12-06-2012 |
20120315250 | PROBIOTIC BIFIDOBACTERIAL COMPOSITION IN ACCORDANCE WITH SECRETOR BLOOD GROUP STATUS - The present invention relates to a probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with non-secretor blood group phenotype. The present invention further relates to a method of tailoring a probiotic composition based on the bifidobacteria found from the intestine of at least one non-secretor individual. | 12-13-2012 |
20120328574 | P38 INHIBITORS - The invention relates to novel p38 MAPK inhibitor which involves | 12-27-2012 |
20130004463 | DNA DAMAGE REPAIR PROMOTER FOR ORAL APPLICATION, AND ELASTASE ACTIVITY INHIBITOR FOR ORAL APPLICATION - To provide a DNA damage repair promoter for oral application and an elastase activity suppressor for oral application. | 01-03-2013 |
20130011368 | Metabolically Active Micro-Organisms and Methods for Their Production - The invention relates to a preparation of metabolically active bacteria, compositions comprising such a preparation, e.g., probiotic supplements or animal feeds, and to uses thereof, for example in the treatment of diseases affecting the intestinal microbial balance. Also described are a growth substrate for microorganisms comprising a mixture of complex and simple sugars and a process for the manufacture of preparations of metabolically active microorganisms using this growth substrate. | 01-10-2013 |
20130022578 | METHODS AND SYSTEM FOR INTERFERING WITH VIABILITY OF BACTERIA AND RELATED COMPOUNDS AND COMPOSITIONS - Provided herein are methods and systems for interfering with viability of bacteria and related compounds and compositions. | 01-24-2013 |
20130028869 | FEED SUPPLEMENT COMPRISING OLIGOSACCHARIDES AND MEDIUM CHAIN FATTY ACIDS - The present invention relates to a feed supplement and a feed containing this feed supplement, comprising 1) a homotrimer, heterotrimer, homotetramer and/or heterotetramer of a carbohydrate component selected from the group consisting of a pentose saccharide, a hexose saccharide, glucuronic and galacturonic acid, and 2) a medium-chain fatty acid (MCFA), selected from the group consisting of caproic acid (C6), caprylic (C8), capric (C10) and lauric acid (C12). The invention also refers to the use of the feed supplement or feed in order to improve the efficiency of animal production, such as weight gain, feed conversion, nutritive value, health and wellbeing through the selective elimination of enteropathogens. | 01-31-2013 |
20130058898 | LACTIC ACID BACTERIUM-CONTAINING PREPARATION - The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium | 03-07-2013 |
20130084265 | DELIVERY SYSTEM FOR BIOLOGICAL COMPONENT - A controlled release delivery system composition and method applied to humans and animals, for oral, anal or vaginal administration of a biological component is disclosed. Preferably, a bacterium is delivered, and more preferably the bacterium is probiotic in nature, however, the biological component is not limited to the bacterium. | 04-04-2013 |
20130095074 | USE OF CAFTARIC ACID AND LACTIC BACTERIUM IN FOOD SUPPLEMENT FOR REGULATING SKIN PIGMENTATION - The present invention relates generally to the field of cosmetic and/or food supplement. More specifically, the present invention aims to provide the use of at least an ingredient containing caftaric acid and/or derivatives and a micro-organism and/or an enzyme capable of hydrolyzing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid, for improving skin tone and preventing and/or treating hyper-pigmentation of skin and/or skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. Also, the present invention aims at providing a skin lightening agent. | 04-18-2013 |
20130101559 | ANTI-MICROBIAL AGENT FROM PAENIBACILLUS SP. AND METHODS AND USES THEREOF - The present invention provides, in part, a | 04-25-2013 |
20130101560 | USE OF ABO TYPE - The present invention relates to use of the ABO blood group genotype of an individual as a criterion for microbiota modulation that is tailored based on the differences in the spectrum of bacteria found between individuals with different ABO blood group genotypes. The present invention relates further to a microbial composition tailored based on the microbial genotypes shown to be specific for A, B, and/or O blood groups. | 04-25-2013 |
20130108585 | CONJUGATED LINOLEIC ACID-PRODUCING STRAINS OF PROBIOTIC BACTERIA AND USE THEREOF FOR THE PREPARATION OF A FOOD, DIETETIC OR PHARMACEUTICAL COMPOSITION | 05-02-2013 |
20130115195 | Anti-Aging Formulations - A dietary supplement based on fucoidan, blue-green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside IV, vitamin D3, vitamin C, anhydrous trimethylglycine and brewers yeast to stimulate stem cell production and reduce the rate of telomere reduction or shortening. This can result in the repair of existing body cells and enhance longevity by stimulating the production of new stem cells and maintaining the telomeres on new stem cells as well as existing cells. The dietary supplement supports an increased life span by enhancing metabolic function, activating SIRT-1 anti-aging genes, and encouraging the production of new cells with longer telomeres. | 05-09-2013 |
20130121968 | Methods of combining metagenome and the metatranscriptome in multiplex profiles - The present invention describes changes in bacterial gastrointestinal, cutaneous and nasal microbiota associated various mammalian medical conditions. Described are diagnostic tests that arise from combining phylogenetic information about the families, genus, and species of the microbiome and their relative abundance with the metabolic information contained in the metatranscriptome to determine the presence and absence of a disease or medical condition. Provided are compositions of bacteria, co-cultures of bacteria and a carrier for use in treating the disclosed medical conditions. The described compositions restore or correct disease- or medical condition-related imbalances in the microbiome profile with culture-conditioned formulations in which the transcriptome activity of the administered organisms is optimized. Alternatively, formulations of metabolites that drive changes in the metatranscriptome native to the mammal that treat disease or a medical condition or restore health are taught. | 05-16-2013 |
20130129684 | METHOD OF INHIBITING METHANOGENESIS - The object of the present invention is to provide a technique to inhibit methanogens from producing methane. The use of | 05-23-2013 |
20130136720 | METHODS OF USING FUT2 GENETIC VARIANTS TO DIAGNOSE CROHN'S DISEASE - The present invention relates to prognosing, diagnosing and treating of Crohn's disease. The invention also provides prognosis, diagnosis, and treatment that are based upon the presence of one or more genetic risk factors at the FUT2 genetic locus. | 05-30-2013 |
20130156738 | BIFIDOBACTERIUM ADOLESCENTIS SPM0212 HAVING ANTIVIRAL ACTIVITY FOR HEPATITIS B VIRUS, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HEPATITIS B COMPRISING THEREOF - The present invention relates to a | 06-20-2013 |
20130156739 | PRODUCT FOR THE UPPER GASTRIC SPHERE - The invention concerns a product for the upper gastric sphere of humans. The product can address acidity in upper gastric sphere of humans. The product of the invention is typically to be administered orally, typically as food or food supplement. The product comprises a base product and several agents that provide benefits to the upper gastric sphere. | 06-20-2013 |
20130171109 | ROTHIA SPECIES GLUTEN-DEGRADING ENZYMES AND USES THEREOF - There are gluten-degrading enzymes found in | 07-04-2013 |
20130189228 | CYANO ANTHRANILAMIDE INSECTICIDES - This invention provides compounds of Formula 1, N-oxides and suitable salts thereof | 07-25-2013 |
20130195803 | BOVINE MILK OLIGOSACCHARIDES - Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided. | 08-01-2013 |
20130195804 | COMPOSITIONS FOR FECAL FLORAL TRANSPLANTATION AND METHODS FOR MAKING AND USING THEM AND DEVICES FOR DELIVERING THEM - In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea, or | 08-01-2013 |
20130209411 | Lactocepins For Use in the Treatment of IP-10-Mediated Inflammatory Diseases - The invention relates to lactocepins and/or a functionally active fragment thereof for use in the prophylaxis and/or the treatment of a disease and to one or more lactocepin(s) and/or one or more functionally active fragment(s) thereof for use in the prophylaxis and/or treatment of IP-10-mediated inflammatory diseases. | 08-15-2013 |
20130209412 | FERMENTED FOOD AND METHOD FOR PRODUCING SAME - The purpose of the present invention is to provide a technique whereby the flavor of products such as fermented milk that use the | 08-15-2013 |
20130236421 | ORAL DOSAGE COMPOSITION - The present invention is an oral dosage composition for prevention and treatment of hepatic inflammation such as NASH. The present invention is an oral dosage composition for prevention or treatment of hepatic inflammation, contains the radical scavenging active spirulina powder effective in preventing, ameliorating, and curing NASH or the like. | 09-12-2013 |
20130236422 | PHARMACEUTICALLY COMPATIBLE METHOD FOR PURIFYING INTACT BACTERIAL MINICELLS - The present invention provides a method for purifying bacterial minicells that involves subjecting a sample containing minicells to density gradient centrifugation in a biologically compatible medium. The method optionally includes a preliminary differential centrifugation step and one or more filtration steps. The invention also provides a method for purifying bacterial minicells in which a sample containing minicells is subjected to a condition that induces parent bacterial cells to adopt a filamentous form, followed by filtration of the sample to separate minicells from parent bacterial cells. The inventive methods optionally include one or more steps to remove endotoxin from purified minicell preparations, and/or treatment of purified minicell preparations with an antibiotic. Additionally, the invention provides purified minicell preparations, prepared according to the foregoing methods, and containing fewer than about 1 contaminating parent bacterial cell per 10 | 09-12-2013 |
20130236423 | OLIGOSACCHARIDE MIXTURE AND FOOD PRODUCT COMPRISING THIS MIXTURE, ESPECIALLY INFANT FORMULA - The invention discloses an oligosaccharide mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide, 5-90 wt % of at least one neutral oligosaccharide, 2-50 wt % of at least one sialylated oligosaccharide, and/or 5-70 wt % of at least one fucosylated oligosaccharide. The invention also discloses a food product, especially an infant formula, comprising said oligosaccharide mixture. | 09-12-2013 |
20130236424 | OLIGOSACCHARIDE COMPOSITION FOR TREATING ACUTE RESPIRATORY TRACT INFECTIONS - The inventions discloses a composition comprising at least one N-acetyl lactosamine, at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide, for use in preventing acute respiratory infections (ARI) and/or relieving symptoms of said ARI infections. Preferably said composition is a starter infant formula. Said acute respiratory infection is in particular bronchiolitis or otitis. | 09-12-2013 |
20130251682 | OLIGOSACCHARIDE COMPOSITION FOR TREATING SKIN DISEASES - The invention discloses a composition comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide and at least one fucosylated oligosaccharide, for use in the prevention and/or treatment of skin conditions and skin diseases. Preferably said composition is a starter infant formula. Said skin disease is in particular atopic dermatitis. | 09-26-2013 |
20130259835 | BIFIDOBACTERIUM ADOLESCENTIS SPM0212 HAVING ANTIVIRAL ACTIVITY FOR HEPATITIS B VIRUS, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HEPATITIS B COMPRISING THEREOF - The present invention relates to a | 10-03-2013 |
20130266540 | MAPK INHIBITION BY H2 - A method of treating and protecting a subject from endotoxin shock by administering a composition including hydrogen, releasing hydrogen in the subject, and down-regulating production of TNF-α and IL-6. A method of treating inflammation in a subject. A method of suppressing hydroxyl radical in a subject. A method of treating inflammation in a subject. A method of reducing the basal level of phosphorylation of MAPKs in non-stimulated monocyte lineage cells in a subject. Methods of performing drug screen tests for compounds that can treat the above conditions. A diagnostic method for diagnosing patients with diseases caused by the MAPK pathway. | 10-10-2013 |
20130287740 | COMPOSITIONS FOR PREPARING A COFFEE BEVERAGE COMPRISING HYDROLYSED CHLOROGENIC ACID - The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage. | 10-31-2013 |
20130295055 | PROBIOTIC COMPOSITION FOR LIVESTOCK, AND METHOD FOR PREPARING SAME - The present invention relates to an eco-friendly probiotic composition, and more particularly, to a probiotic composition for livestock production, comprising a lactic acid bacteria culture medium and an organic acid, wherein the organic acid is contained in an amount of 0.002 to 0.1 parts by weight relative to 1 parts by weight of the lactic acid bacteria culture medium. The present invention also relates to a method for preparing the composition. The eco-friendly probiotic composition of the present invention does not contain antibiotics and may exhibit complex effect of sterilization and virucidal effectiveness. | 11-07-2013 |
20130309204 | VEGETABLE OILS AS NITROGEN FIXING BACTERIA PRESERVATIVE - Methods of preserving the life span of nitrogen-fixing bacteria in agricultural pesticide formulations using vegetable oils. | 11-21-2013 |
20130323208 | MYCOBACTERIUM BRUMAE CELL WALL EXTRACTS THAT CAN BE USED IN THERAPY OF SUPERFICIAL BLADDER CANCER - Invention is using | 12-05-2013 |
20140004083 | CRYOPROTECTIVE COMPOSITIONS AND USES THEREOF | 01-02-2014 |
20140030228 | Methods and Compositions of Biocontrol of Plant Pathogens - The present invention comprises methods and composition for control of plant pathogens. Isolated bacteria, deposited with ATCC under the Budapest Treaty, are effective to control plant pathogens. | 01-30-2014 |
20140050703 | EQUOL-PRODUCING LACTIC ACID BACTERIA-CONTAINING COMPOSITION - An equol-producing lactic acid bacteria-containing composition comprises, as an essential component thereof, a lactic acid bacterial strain belonging to the genus | 02-20-2014 |
20140056852 | BIFIDOBACTERIUM BIFIDUM STRAINS FOR APPLICATION IN GASTROINTESTINAL DISEASES - The present invention provides a strain of | 02-27-2014 |
20140056853 | Compositions and Methods for Modulating Plant Parasitic Nematodes - Provided is a method for modulating soybean cyst nematode infestation of a plant comprising applying to the plant an effective amount of a composition comprising a | 02-27-2014 |
20140072533 | METHOD OF MAKING COSMETIC COMPOSITIONS CONTAINING A PREBIOTIC - A method for indentifying test agents that exhibit prebiotic activity on human skin commensal microorganisms and cosmetic compositions that include such agents. The method includes providing a test culture of a test agent, a human skin commensal microorganism and a minimal carbon medium. The method provides a time efficient and cost effective way to predict in vivo prebiotic activity of a test agent on skin commensal microorganisms. | 03-13-2014 |
20140072534 | NOVEL THERAPY FOR MULTIPLE SCLEROSIS USING VITAMIN D AND GUT BACTERIA - A method for treating multiple sclerosis in a subject in need of such treatment is provided. The method includes administering a) polysaccharide A and b) vitamin D or a vitamin D metabolite to the subject in an amount effective to treat multiple sclerosis. Also provided is a method for increasing T | 03-13-2014 |
20140072535 | METHOD OF INHIBITING METHANOGENESIS - The object of the present invention is to provide a technique to inhibit methanogens from producing methane. The use of | 03-13-2014 |
20140086876 | BIOCONTROL COMPOSITIONS - The invention provides isolated | 03-27-2014 |
20140086877 | BACTERIOTHERAPY FOR CLOSTRIDIUM DIFFICILE COLITIS - This document discusses, among other things, receiving a plurality of donor fecal samples from a plurality of donors and storing and indexing each respective donor fecal samples using at least one characteristic of the respective donor fecal sample. In an example, the donor fecal sample can be screened and processed for subsequent use in fecal bacteriotherapy to displace pathogenic or undesired organisms in the digestive track of a patient with healthy or desirable gut micriobiota. | 03-27-2014 |
20140093478 | GUT MICROBIOME AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR AN OBESITY RELATED DISORDER - The present invention relates to the gut microbiome as a biomarker and therapeutic target for energy harvesting, weight loss or gain, and/or obesity in a subject. In particular, the invention provides methods of altering and monitoring the relative abundance of | 04-03-2014 |
20140093479 | PROBIOTIC BACTERIAL STRAINS AND SYMBIOTIC COMPOSITION CONTAINING THE SAME INTENDED FOR INFANT FOOD - Selection of probiotic strains belonging to the genus | 04-03-2014 |
20140105864 | COMPOSITIONS COMPRISING PHYTOESTROGENS SELECTIVE FOR ESTROGEN BETA RECEPTOR AND DIETARY FIBRES - Oral compositions comprising an association of one or of a mixture of phytoestrogens, selective for the estrogen receptor-β, with dietary fibres are described. The compositions thereof can be profitably used for the prophylactic and therapeutic treatment in mammals, including humans, of health conditions characterised by a high risk of onset and recurrence of intestinal adenomas (adenopolyposis coli), and of adenoma's progression to colorectal carcinoma. In presence of pre-cancerous lesions in the colon, characterised by mutations of the APC tumor suppressor and defined as polyps or adenomas, the oral compositions disclosed can be in fact profitably used to reduce the number and volume of polyps, and to prevent their progression to neoplastic transformation, reducing their degree of dysplasia. | 04-17-2014 |
20140105865 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 04-17-2014 |
20140120063 | NUTRITIONAL AND METABOLIC APPROACHES TO PREVENT EMERGENCE OF ENTERIC PATHOGENS - Antibiotic-associated enteric pathogens are shown to increase in mucosal carbohydrate availability that occur upon disruption of the competitive ecosystem. Transient post-antibiotic increase in monosaccharides liberated by the resident microbiota from host mucus provides a window of opportunity for these pathogens to expand to densities sufficient to induce self-promoting host inflammation. | 05-01-2014 |
20140127164 | BACTERIAL STRAINS BELONGING TO THE GENUS BIFIDOBACTERIUM FOR USE IN THE TREATMENT OF HYPERCHOLESTEROLAEMIA - Selected bacterial strains belonging to the genus | 05-08-2014 |
20140127165 | ISOXAZOLINE INSECTICIDES - Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, | 05-08-2014 |
20140127166 | SUPPLEMENTION OF MATERNAL DIET - The use of probiotic bacteria in the manufacture of a composition for administration to a woman in at least the third trimester of pregnancy for prevention of gestational diabetes, normalizing plasma glucose concentration and/or increasing insulin sensitivity. | 05-08-2014 |
20140134135 | METHODS AND COMPOSITIONS FOR PRESERVING LEAN BODY MASS DURING WEIGHT LOSS - The invention provides compositions and methods for preserving lean body mass during weight loss in an animal. The methods comprise administering OEA to the animals, preferably in amounts of from about 0.01 to about 1000 mg/kg/day. | 05-15-2014 |
20140147417 | COMPOSITIONS AND METHODS FOR TRANSPLANTATION OF COLON MICROBIOTA - The present invention provides compositions that include an extract of human feces, and methods for using such compositions, including methods for replacing or supplementing or modifying a subject's colon microbiota, and methods for treating a disease, pathological condition, and/or iatrogenic condition of the colon. | 05-29-2014 |
20140154217 | LACTOCOCCUS LACTIS STRAINS, AND BACTERIAL PREPARATIONS THEREOF, FOR THE PRODUCTION OF BIOACTIVE PEPTIDES HAVING ANTI-HYPERTENSIVE AND CHOLESTEROL-LOWERING EFFECTS IN MAMMALS; NUTRITIONAL AND THERAPEUTIC PRODUCTS PRODUCED THEREFROM | 06-05-2014 |
20140154218 | ANTI-ALLERGIC AGENT - According to the present invention, an anti-allergic agent is provided which includes a polysaccharide comprising galactose, glucose and rhamnose as constituents, or includes a microorganism belonging to a genus | 06-05-2014 |
20140186302 | Nutritional Formulations and Method for Treating Diseases - The present invention provides methods for treating retinal disorders using a nutraceutical composition comprising lutein and zeaxanthin. Methods for treating vitreomacular traction disorder and related disorders are disclosed. | 07-03-2014 |
20140193369 | ANTI-INFLAMMATORY FOOD PRODUCT - According to some embodiments, a method selects one or more inflammatory markers to evaluate. The one or more inflammatory markers selected from the group consisting of iNOS, COX-2, TNF-alpha, NO, PGE | 07-10-2014 |
20140193370 | METHODS AND COMPOSITIONS FOR PROMOTING LEAN BODY MASS GROWTH - The invention provides methods for promoting lean body mass growth in an animal. The methods comprise administering OEA to the animals, preferably in amounts of from about 0.01 to about 1000 mg/kg/day. | 07-10-2014 |
20140193371 | Method for the Prevention and Treatment of Cancer, Tuberculosis and Related Diseases - A method for preventing and treating one or more disease states including the steps of altering the diet of an individual and then administering a drug to the individual. Plasma vitamin C level is reduced from a first level to a second level that is lower than the first level, such that a pharmacological response of the body of the individual to a drug at the first level is different from the pharmacological response of the body of said individual to the drug at the second level. | 07-10-2014 |
20140193372 | REDUCING SHORT-CHAIN FATTY ACIDS AND ENERGY UPTAKE IN OBESE HUMANS BY MANAGING THEIR INTESTINAL MICROBIAL COMMUNITIES - The present invention provides for microbial compositions and methods for reducing the concentration of short-chain fatty acids in the gut as a way to reduce energy uptake and manage obesity. More specifically, the invention provides for decreasing short-chain fatty acids available for absorption in the human gut, such as acetate, using one or more of: a probiotic including a homo-acetogenic, acetate oxidizing bacterium that converts acetate to H | 07-10-2014 |
20140199269 | Chromobacterium Bioactive Compositions and Metabolites - Provided are bioactive compounds and metabolites derived from | 07-17-2014 |
20140199270 | METHODS AND COMPOSITIONS TO REDUCE FAT GAIN, PROMOTE WEIGHT LOSS IN MAMMALS - The present disclosure relates to compositions and related methods to reduce body weight, body fat, waist and hip size, plasma total cholesterol, LDL, triglycerides, blood glucose, leptin and C-reactive protein levels and increase in HDL and serotonin levels in an mammal. The LeptiCore® formulation disclosed, at both the low and high dosages, is helpful in the management of fat gain and its related complications. The higher dosage resulted in significantly greater reductions in body weight and triglyceride, blood glucose, and C-reactive protein levels, as well as increased serotonin levels. | 07-17-2014 |
20140212387 | LIQUID PREPARATION FOR BIOLOGICAL PLANT PROTECTION, METHOD FOR PRODUCING IT AND USE THEREOF - The invention relates to a liquid preparation comprising biologically active fungi and/or fungal organs and/or other microorganisms in a suspension, to a method for producing it and to the use thereof for biological protection of plants, for biological plant strengthening, or for biological soil improvement. Polyether-modified trisiloxane is a preferred liquid used. The preparation according to the invention is notable for easily manageable storage at room temperature, trouble-free transport, and simplicity of production and application. | 07-31-2014 |
20140212388 | Composition For Cosmetic And Health Improvement - The invention relates to compositions in a form of health drinks, capsules, tablets or powders. In particular the compositions improve individual's general health, maintain and improve regeneration of human connective tissue and simultaneously provide positive cosmetic effects for a better life and more happiness for all, male, female, young and old. The composition may include compounds such as silica compound, biotin, carnosine, hyaluronic acid, methylsulfonyl methane (MSM), dimethylethanolamine (DMEA) and omega-3-oil along with other components. | 07-31-2014 |
20140212389 | NUTRITIONAL COMPOSITION COMPRISING PROBIOTICS AND IMPROVING SLEEP PATTERNS - This invention relates to the use of a probiotic bacterial strain in the manufacture of a medicament or therapeutic nutritional composition for improving the maturation of sleep patterns in infants, young children or young animals and/or for reducing sleep disturbances and/or improving sleep patterns in humans or animals at any age. | 07-31-2014 |
20140219967 | Poly (3-Hydroxybutyrate/3-Hydroxyvalerate) of Lowered Crystallinity for Use in Animal Feed - Animal feed conversion ratio can be increased and blood glucose levels can be decreased by feeding an efficacious amount of dispersible amorphous poly(3-hydroxybutyrate/3-hydroxyvalerate). | 08-07-2014 |
20140242035 | METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS - Methods for the treatment of a cell proliferation disorder in a subject, involving:
| 08-28-2014 |
20140255352 | NON-CHEMOTHERAPEUTIC ANTIBIOTIC TREATMENT FOR INFECTIONS IN CATTLE - Compositions and methods for treating and/or preventing bacterial infections in animals such as bovines are provided. The compositions and methods utilize the predatory bacterium | 09-11-2014 |
20140271552 | Nutritional Compositions Containing a Peptide Component and Uses Thereof - The present disclosure relates to nutritional compositions including a protein equivalent source including a peptide component comprising selected peptides from Tables 1 and 2 disclosed herein. The protein equivalent source may further include intact protein, hydrolyzed protein, including partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the incidence of autoimmune disease and/or diabetes mellitus by providing said nutritional compositions to a target subject, which includes a pediatric subject. | 09-18-2014 |
20140271553 | Nutritional Compositions Containing A Peptide Component with Anti-Inflammatory Properties and Uses Thereof - The present disclosure relates to nutritional compositions comprising a protein equivalent source, wherein 20% to 80% of the protein equivalent source includes a peptide component comprising SEQ ID NO 4, SEQ ID NO 13, SEQ ID NO 17, SEQ ID NO 21, SEQ ID NO 24, SEQ ID NO 30, SEQ ID NO 31, SEQ ID NO 32, SEQ ID NO 51, SEQ ID NO 57, SEQ ID NO 60, and SEQ ID NO 63, and 20% to 80% of the protein equivalent source comprises an intact protein, a partially hydrolyzed protein, or combinations thereof. The disclosure further relates to methods of reducing the inflammatory response and/or production of proinflammatory cytokines, i.e. Interleukin-17, by providing said nutritional compositions to a target subject. | 09-18-2014 |
20140271554 | Reducing Proinflammatory Response - The present disclosure provides a method for suppressing a proinflammatory response by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition may reduce the levels of proinflammatory cytokines and may be a treatment for inflammatory disease, especially type 1 diabetes. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da. | 09-18-2014 |
20140271555 | ACTIVATING ADIPONECTIN BY CASEIN HYDROLYSATE - The present disclosure provides a method for activating adiponectin by administering a composition comprising peptides selected from a casein hydrolysate. Such a composition may reduce risk of heart attack and help in maintaining healthy weight. Preferably, the hydrolysate consists of peptides with a molecular weight of more than 500 Da. | 09-18-2014 |
20140271556 | Magnetic Acoustic Resonance Light and Homeopathic Therapy Crystal - A quartz or otherwise similar crystal (‘host crystal’) embedded with minerals, metals, homeopathic, organic/inorganic, and magnetic materials (which allow for magnetic interactions) and the method for embedded ‘host crystal’ with said materials is disclosed. The ‘host crystal’ can be any size, shape, cut, or color of crystal. A hole/depression is first drilled/etched anywhere on the quartz or similar ‘host crystal’, this hole is then filled with a chosen combination of materials using force/compression, and are semi-permanently sealed by compressing metal flake or powder onto/into the top of the material-filled hole in the ‘host crystal’. The compression of the materials inside of the ‘host crystal’ increases the natural piezoelectric, ionic emission, magnetic field, and vibrational properties/emissions, allows for magnetic interactions, increases their scientific and potential therapeutic effects, and has applications for decorative specimens, energy healing/homeopathic/vibrational therapies, water energizing/structuring, and is most often incorporated into gem, mineral, magnetic, and homeopathic light therapies. | 09-18-2014 |
20140271557 | METHODS OF DIAGNOSING AND TREATING CANCER BY DETECTING AND MANIPULATING MICROBES IN TUMORS - In some embodiments, methods of determining that a subject is likely to have cancer are provided. Such methods may include amplifying a microbial DNA sample in a test sample obtained from the subject to determine an amount of microbial DNA in the test sample, wherein the amount of microbial DNA is determined by an amplification or sequencing technique; and determining that the subject is likely to have breast cancer when there is a significantly decreased level of microbial DNA in the test sample when compared to a level of microbial DNA in a control sample. In other embodiments, methods of treating cancer (e.g., breast cancer) are provided. In one aspect, such methods include administering a therapeutically effective dose of a probiotic organism via ductal lavage to a subject suffering from the breast cancer. | 09-18-2014 |
20140271558 | Dietary Supplements Including Glucan and Fulvic Acid - Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan. | 09-18-2014 |
20140271559 | COMPOSITIONS AND METHODS FOR THE PRODUCTION AND DELIVERY OF DOUBLE STRANDED RNA - Compositions and methods for efficiently producing and delivering double stranded RNA (dsRNA) are provided. Vector constructs useful for in vitro and in vivo expression of dsRNA are described. Also described are cell expression systems for efficient and cost-effective production of dsRNA in living cells and methods and compositions for providing the expressed dsRNA to target organisms. The described compositions and methods can be used to produce RNA molecules for screening or other uses, and to amplify RNA sequences for analysis. | 09-18-2014 |
20140271560 | Methods for Using Cryptococcus Flavescens Strains for Biological Control of Fusarium Head Blight - Disclosed are methods of identifying subspecies of | 09-18-2014 |
20140271561 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS - The invention described herein provides for methods and systems for determining, selecting, and/or treating diseases and conditions caused by or associated with high quantities of methanogens in a subject, or diseases and conditions caused by or associated with low quantities of methanogens in a subject. In various embodiments, a therapy to inhibit the growth of methanogens or to promote the growth of methanogens are selected and/or administered to a subject in need thereof. | 09-18-2014 |
20140271562 | COMPOSITION FOR USE IN BRAIN GROWTH AND/OR COGNITIVE AND/OR PSYCHOMOTOR DEVELOPMENT - The invention discloses a composition comprising at least one long chain polyunsaturated fatty acid, at least one probiotic and a mixture of oligosaccharides, said mixture containing at least one N-acetylated oligosaccharide, at least one sialylated oligosaccharide and at least one neutral oligosaccharide, for use in brain growth and/or cognitive and/or psychomotor development. This composition is particularly adapted for use in infants, notably preterm infants. | 09-18-2014 |
20140271563 | EFFECT OF AN ATTENUATED BORDETELLA STRAIN AGAINST ALLERGIC DISEASE - Described herein are compositions, vaccines, and methods that include use of a mutated | 09-18-2014 |
20140286908 | COMPOSITION FOR USE IN THE PROMOTION OF INTESTINAL ANGIOGENESIS AND OF NUTRIENT ABSORPTION AND OF ENTERAL FEEDING TOLERANCE AND/OR IN THE PREVENTION AND/OR TREATMENT OF INTESTINAL INFLAMMATION AND/OR IN THE RECOVERY AFTER INTESTINAL INJURY AND SURGERY - The invention discloses a composition comprising at least one long chain polyunsaturated fatty acid, at least one probiotic and a mixture of oligosaccharides, said mixture containing at least one N-acetylated oligosaccharide, at least one sialylated oligosaccharide and at least one neutral oligosaccharide, for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation, such as necrotizing enterocolis, and/or in the recovery after intestinal injury and/or surgery. This composition is particularly adapted for use in infants, notably preterm infants. | 09-25-2014 |
20140286909 | COMPOSITION FOR USE IN INCREASING INSULIN SENSITIVITY AND/OR REDUCING INSULIN RESISTANCE - The invention discloses a composition comprising at least one long chain polyunsaturated fatty acid, at least one probiotic and a mixture of oligosaccharides, said mixture containing at least one of lacto-N-neotetraose (LNnT) and lacto-N-tetraose (LNT), at least one N-acetylated oligosaccharide different from LNnT and LNT, at least one sialylated oligosaccharide and at least one neutral oligosaccharide, for use in increasing insulin sensitivity and/or reducing insulin resistance. This composition optionally further comprises 2′-fucosyllactose (FL). This composition is particularly adapted for use in infants who were born preterm and/or who experienced IUGR, in pregnant women suffering from gestational diabetes and in children, adolescents, and adults suffering from insulin resistance and/or type II diabetes. | 09-25-2014 |
20140294773 | MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF - A clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for adaptive antiviral defence (Cascade); the Cascade protein complex comprising at least CRISPR-associated protein subunits Cas7, Cas5 and Cas6 which includes at least one subunit with an additional amino acid sequence possessing nucleic acid or chromatin modifying, visualising, transcription activating or transcription repressing activity. The Cascade complex with additional activity is combined with an RNA molecule to produce a ribonucleoprotein complex. The RNA molecule is selected to have substantial complementarity to a target sequence. Targeted ribonucleoproteins can be used as genetic engineering tools for precise cutting of nucleic acids in homologous recombination, non-homologous end joining, gene modification, gene integration, mutation repair or for their visualisation, transcriptional activation or repression. A pair of ribonucleotides fused to Fold dimers may be used to generate double-strand breakages in the DNA to facilitate these applications in a sequence-specific manner. | 10-02-2014 |
20140294774 | METHOD FOR PREVENTING AND/OR TREATING INSULIN RESISTANCE - Described is the use of | 10-02-2014 |
20140322170 | Fermented Flavoring System Derived from Greek Yogurt Processing - Disclosed are methods for producing flavoring ingredients, ready-to-drink formulations, protein powder mixes and pre-mixes, yogurt-flavored cereal binders for use in cereal clusters and bars, etc., from Greek yogurt whey (i.e., Greek acid whey). | 10-30-2014 |
20140322171 | USE OF CHROMOBACTERIUM SUBSTUGAGE FORMULATIONS, COMPOSITIONS AND COMPOUNDS TO MODULATE CORNWORM ROOTWORM LARVAE INFESTATION - Provided is the use of or compositions or formulations comprising | 10-30-2014 |
20140322172 | LIPID METABOLISM AND/OR SUGAR METABOLISM IMPROVER CONTAINING LACTIC ACID BACTERIUM OR TREATMENT PRODUCT THEREOF - This invention provides the use of a microorganism capable of improving both lipid metabolism and sugar metabolism. Specifically, the invention relates to: a lipid metabolism and/or sugar metabolism improver comprising, as an active ingredient, a bacterial cell selected from bacteria belonging to the genus | 10-30-2014 |
20140348797 | METHOD FOR INHIBITING PROLIFERATION OF PLANT PATHOGENIC MICROBE USING COLLIMONAS BACTERIUM - To provide a method for inhibiting the proliferation of a plant pathogenic bacterium. A method for inhibiting the proliferation of a plant pathogenic bacterium, including culturing a microorganism having an ability to inhibit the proliferation of a plant pathogenic bacterium and belonging to the genus | 11-27-2014 |
20140363398 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 12-11-2014 |
20140363399 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 12-11-2014 |
20140363400 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag. | 12-11-2014 |
20140369965 | BIFIDOBACTERIUM CECT 7765 AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF OVERWEIGHT, OBESITY AND ASSOCIATED PATHOLOGIES - The present invention relates to the | 12-18-2014 |
20140369966 | PREVENTIVE AND/OR AMELIORATIVE AGENT FOR DISEASES, STAMINA ENHANCEMENT AGENT, ANTI-FATIGUE AGENT, AND PHARMACEUTICAL AND FOOD AND DRINK USING THEM - A purple non-sulfur bacteria useful in preventing and/or ameliorating at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and having high safety is provided. A preventive and/or ameliorative agent is for at least one disease selected from the group consisting of inflammatory diseases, allergic diseases, and autoimmune diseases and includes at least one of a purple non-sulfur bacteria and a culture material obtained by culturing the purple non-sulfur bacteria. The purple non-sulfur bacteria includes | 12-18-2014 |
20140377225 | METHODS OF IMPROVING BONE HEALTH AND MUSCLE HEALTH - The present invention comprises a method of improving bone health and muscle health in a companion animal comprising administering a composition comprising a fatty acid component to the companion animal wherein the fatty acid component comprises a ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) from about 3:1 to about 25:1. The present invention additionally comprises a composition comprising a fatty acid component comprising docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) wherein the ratio of docosahexaenoic acid (DHA) to eicosapentaenoic acid (EPA) is from about 3:1 to about 25:1. | 12-25-2014 |
20150010511 | OIL-BASED PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISEASES - The present invention relates to a composition for oral use in the treatment of gastrointestinal pathologies comprising silicone antifoaming agents in an oily solvent medium, wherein the concentration of said silicone antifoaming agents is between 0.1% and 80% by weight. | 01-08-2015 |
20150023925 | CONJUGATED LINOLEIC ACID-PRODUCING STRAINS OF PROBIOTIC BACTERIA AND USE THEREOF FOR THE PREPARATION OF A FOOD, DIETETIC OR PHARMACEUTICAL COMPOSITION - The present invention relates to conjugated linoleic acid (CLA)-producing strains of probiotic bacteria. In particular, the present invention relates to a selection of bacterial strains belonging to the genus | 01-22-2015 |
20150030566 | ANTIMICROBIAL PEPTIDE COMPOSITIONS FOR PLANTS - Compositions containing one or more tyrocidines, tryptocidines, phenycidines and/or gramicidin S, or derivatives and analogues thereof, are described for controlling antimicrobial growth on plants, plant material or plant growth media, and methods for controlling or preventing the growth of microbial pathogens, and in particular fungal pathogens, on plants, plant parts and plant material are described herein. The active agents used to control these pathogens are tyrocidines, tryptocidines, phenycidines and/or gramicidin S, or derivatives, analogues or modifications thereof. The tyrocidines, tryptocidines, phenycidines and/or gramicidin S are cyclic decapeptides having the general amino acid sequence cyclo(valine-Xrleucine-D-phenylalanine-proline-X | 01-29-2015 |
20150037286 | USE OF ROSEBURIA IN THE PREVENTION AND TREATMENT FOR OBESITY RELATED DISEASES - The present invention provides use of | 02-05-2015 |
20150044174 | COMPOSITION FOR IMPROVING EYE HEALTH - The present invention relates to a composition for promoting eye health in a companion animal. The composition comprising: at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffeic acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof. | 02-12-2015 |
20150050246 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE - Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method may include a method of treating an infection. The method may comprise administering a microbiota restoration therapy composition to a patient with an infection. The microbiota restoration therapy composition may comprise a mixture of an effective amount of fecal microbiota and an effective amount of polyethylene glycol. | 02-19-2015 |
20150071884 | Nutrition Composition - The present invention resides in a composition comprising ingredients providing one or more of: omega 3 and 6 fatty acids; cis fats; vitamins A, B, C, D, E and K; one or more alkalyzing agent; one or more anti-inflammatory agent; one or more immune system enhancing agent; a protein source; one or more antioxidants; one or more blood sugar regulator; one or more sweetener; one or more mineral; and one or more adaptogen. Ideally, such a composition is for use in sport nutrition. | 03-12-2015 |
20150079042 | Natural Pet Treat and Method of Production - The invention disclosed herein is directed to a pet treat composition and the method of producing such a composition. The pet treat comprises a mixture of whole wheat flour, blueberries, cinnamon, vanilla yogurt, and almond milk. The composition includes organic and natural ingredients and contains a high level of antioxidants, which provides anti-inflammatory properties that help prevent joint and hip pain. Additionally, the composition contains probiotics that enhance digestive function. When consumed, the probiotics have shown to help the chemical balance and reduce tearing as well as the bacteria that causes tear stains. The present method generally involves mixing all of the ingredients together to form a dough and baking the dough. The composition is suitable for daily consumption and as supplement to a pet's existing diet regimen. | 03-19-2015 |
20150079043 | USE OF BURKHOLDERIA FORMULATIONS, COMPOSITIONS AND COMPOUNDS TO MODULATE CROP YIELD AND/OR CORN ROOTWORM INFESTATION - Provided is the use of or compositions or formulations comprising | 03-19-2015 |
20150098928 | ISOXAZOLINE INSECTICIDES - Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, | 04-09-2015 |
20150104424 | Animal Health Improvement Composition and Method - Compositions and methods are provided for improving the health of an animal by reducing certain diseases and by binding certain heavy metals that may be unintentionally introduced into the body of the animal from the environment. Compositions and methods are also provided for improving the feed conversion ratio of an animal. In addition, compositions and methods are provided for reducing nitrate pollution in the environment. In one embodiment, the composition may include mastic gum, a mixture of ionic minerals, and optionally an essential amino acid not produced by the animal. The ionic minerals may be derived from water sourced from an inland sea such as the Great Salt Lake, the Dead Sea, or another inland sea. The essential amino acid may be included in the form of a protein. The animal may be a ruminant, poultry, or other animal. Methods are also provided for processing mastic gum. | 04-16-2015 |
20150104425 | Medical food for high cortisol breast cancer - A method of increasing effectiveness of breast cancer treatment or recovery using a medical food. This breast cancer medical food consists of transfer factor, lactic acid generating bacteria, and/or glucans in appropriate combinations. The breast cancer medical food, administered correctly, reduces cortisol levels and enhances immune function. This method is applied to breast cancer patients with high cortisol levels. Dosage amounts are adjusted for client weight. Consumption frequency and dosage may be adjusted in response to cortisol measurements and killer T-cell-counts. Typically, consumption of the breast cancer medical food is done under professional supervision, and may be combined with other treatment strategies. | 04-16-2015 |
20150110744 | PEPTIDE AGENTS FOR CANCER THERAPY - There is provided peptides for inhibiting growth of cancer cells, the peptides comprising the amino acid sequence RxKxKxxxxR wherein K and R are respectively lysine and arginine amino acid residues, each x is independently an amino acid, and 5 wherein the peptide has 50% or less amino acid sequence identity with the amino acid sequence RSKAKNPLYR (SEQ ID. No. 2). Each x amino acid may independently be an amino acid residue selected from the group consisting of alanine (A), valine (V), leucine (L), isoleucine (I), threonine (T) and serine (S) amino acid residues. There is also provided chimeric proteins incorporating a peptide of the amino acid sequence 10 RxKxKxxxxR, nucleic acids encoding for the peptide, expression vectors including a nucleic acid encoding the peptide for expression of the peptide, and methods for use of the peptide for inhibiting growth of cancer cells. | 04-23-2015 |
20150118192 | COMPOSITIONS AND METHODS FOR MODULATING PLANT PARASITIC NEMATODES - Provided is a method for modulating soybean cyst nematode infestation of a plant comprising applying to the plant an effective amount of a composition comprising a | 04-30-2015 |
20150125426 | MEDIUM CHAIN DICARBOXYLIC ACIDS, THEIR DERIVATES AND METABOLIC DISORDERS - A composition comprising medium chain dicarboxylic acids and/or derivatives of medium chain dicarboxylic acids can be used to treat or prevent metabolic disorders. The composition can particularly well be used to treat or prevent hyperglycemia, for example diabetes. | 05-07-2015 |
20150132264 | BACTERIUM FOR USE AS A PROBIOTIC FOR NUTRITIONAL AND MEDICAL APPLICATIONS - A first aspect of the invention relates to the bacterial species | 05-14-2015 |
20150139955 | AGENT FOR PROMOTING PROLIFERATION OF BIFIDOBACTERIA - A peptide dimer comprising a peptide consisting of the amino acid sequence of SEQ ID NO: 1 and a peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4, wherein the peptide consisting of the amino acid sequence of SEQ ID NO: 1 and the peptide consisting of any one of the amino acid sequences of SEQ ID NOS: 2 to 4 are bound through a disulfide bond between a cysteine residue of each peptide is used as an active ingredient of an agent for promoting proliferation of one or more bacterium selected from the group consisting of | 05-21-2015 |
20150139956 | COMPOSITIONS WHICH REGULATE THE EPITHELIAL BRUSH BORDER Na+/H+ EXCHANGER NHE3 AND THEIR METHODS OF USE IN GASTROINTESTINAL DISEASE - A synthetic peptide modeled on the IRCX binding area of NHE3, is a competitive inhibitor of the IRCX and both stimulates basal NHE3 activity and prevents elevated Ca | 05-21-2015 |
20150139957 | GROWTH ENHANCING ADDITIVE FROM POMEGRANATE PLANT FOR POULTRY FEED - A method for enhancing the growth, increasing feed utilization and reducing mortality in poultry (such as chickens and turkeys) by adding a pomegranate-derived additive to their feed. Pomegranate-derived additive and its use for enhancing growth of poultry without growth-promoting antibiotics. | 05-21-2015 |
20150139958 | Feed Composition and Production Method for Same - Provided are a feed composition, which can be stored for a long time and is easily produced and adjustable in components, and which can increase the body weight and reduce a feed conversion ratio of farm animals to which the feed composition is fed, and a production method for the feed composition. In the feed composition, a liquid feed additive obtained by fermenting a carbohydrate-containing carbohydrate raw material by | 05-21-2015 |
20150139959 | Bacterial Isolate, Methods of Isolating Bacterial Isolates and Methods for Detoxification of Trichothecene Mycotoxins - The invention provides a bacterial isolate defined by accession number 040408-1 filed with the International Depository Authority of Canada. The bacteria are capable of detoxifying trichothecene mycotoxins. Also provided are compositions including the bacteria and methods of preventing or treating food or foodstuffs that are contaminated or susceptible to contamination with trichothecene mycotoxins. Kits are also provided. | 05-21-2015 |
20150147298 | Sleep enhancement with cortisol reduction medical food - A method of using a sleep enhancement medical food to improve human sleep quality. This sleep enhancement medical food consists of transfer factor, lactic acid generating bacteria, and/or glucans in appropriate combinations. The sleep enhancement medical food, administered correctly, reduces cortisol levels. High cortisol causes insomnia. Dosage amounts are adjusted for client weight. Consumption frequency and dosage may be adjusted in response to cortisol measurements. Typically, consumption of the sleep enhancement medical food is done under professional supervision, and may be combined with other treatment strategies. | 05-28-2015 |
20150290256 | PREVOTELLA HISTICOLA PREPARATIONS AND THE TREATMENT OF AUTOIMMUNE CONDITIONS - This document provides methods and materials related to | 10-15-2015 |
20150290258 | SYNBIOTIC COMPOSITION AND USE THEREOF - The invention relates to a synbiotic composition, its use for the inhibition of pathogen infection, especially in the gut, as well as food compositions comprising said synbiotic composition. | 10-15-2015 |
20150297506 | USE OF PROBIOTIC MICRO-ORGANISMS AS AN AGENT THAT PROMOTES THE SYNTHESIS OF MELANIN - The present invention relates to the oral use of | 10-22-2015 |
20150306152 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS - The present invention relates to | 10-29-2015 |
20150313844 | MICROPARTICLES COMPRISING A PROBIOTIC, CROSS-LINKABLE REAGENT, A DENATURED PROTEIN, POLYOL PLASTICISER AND TREHALOSE - The present invention relates to microparticles, methods of producing microparticles and microparticle precursor compositions. In particular, it relates to microparticles comprising a protective matrix and a protective matrix precursor composition comprising a blend of a denatured protein, a polyol plasticizer, trehalose and a carrier. | 11-05-2015 |
20150313952 | SYNBIOTIC COMPOSITION AND USE THEREOF - The invention relates to a synbiotic composition, its use for use the establishment and/or the maintenance of a healthy gut environment, as well as food compositions comprising said synbiotic composition. | 11-05-2015 |
20150320830 | ANTI-MICROBIAL AGENT FROM PAENIBACILLUS SP. AND METHODS AND USES THEREOF - The present invention provides, in part, a | 11-12-2015 |
20150328266 | Use of Bifidobacterium Animalis for Treating or Preventing Body Weight Gain and Insulin Resistance - Provided is the use of | 11-19-2015 |
20150335053 | PREVENTING DISEASES IN INFANTS DELIVERED VIA CAESAREAN SECTION - The present invention provides the use of a composition comprising non-digestible oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section. | 11-26-2015 |
20150343002 | USE OF PROBIOTIC MICRO-ORGANISMS AS AN AGENT THAT PROMOTES THE SYNTHESIS OF MELANIN - The present invention relates to the topical use of | 12-03-2015 |
20150366919 | SYNBIOTICS COMBINATION FOR BRAIN IMPROVEMENT - The invention relates to nutritional compositions with | 12-24-2015 |
20150366941 | HUMAN DISEASE TREATMENT WITH MEDICAL FOOD FORMULATION - A method of using a medical food containing at least transfer factor and lactic acid generating bacteria to mitigate the symptoms of a specific human disease. Another medical food formulation consists of transfer factor, lactic acid generating bacteria, and glucans in appropriate combinations. Other components may be added. The medical food, administered correctly, reduces cortisol levels, builds the immune system, and balances the endocrine system. Dosage amounts are adjusted for client weight. Medical foods may be used with other treatment options. | 12-24-2015 |
20160008411 | BACTERIAL STRAINS HAVING AN OUTSTANDING ABILITY TO PRODUCE MENAQUINONE | 01-14-2016 |
20160015757 | MICROBIAL COMPOSITIONS COMPRISING RUMEN MICROFLORA AND USES THEREOF - A method of mimicking a phenotype of a first ruminating animal in a second ruminating animal is disclosed. The method comprises administering to the second ruminating animal a microbial composition comprising a plurality of microbes having a signature which is statistically significantly similar to the microbial signature of a rumen microbiome of the first ruminating animal, wherein the first and the second ruminating animal are of identical species, thereby mimicking the phenotype of the first ruminating animal in the second ruminating animal. | 01-21-2016 |
20160021890 | INHIBITING OR REDUCING FUNGAL GROWTH - Provided are methods and compositions for inhibiting or reducing fungal growth. The methods comprise exposing a location to a composition comprising one or more enzymes, one or more bacteria, and/or an enzymatic extract, wherein the one or more enzymes, one or more bacteria, and/or the enzymatic extract isolated from one or more bacteria are exposed to location in a quantity sufficient to inhibit or reduce fungal growth. | 01-28-2016 |
20160051596 | NOVEL ACETOBACTER AND GLUCONACETOBACTER STRAINS AND THEIR METABOLITES FOR USE IN INHIBITING XANTHINE OXIDASE - A method for inhibiting xanthine oxidase and for reducing uric acid levels using a composition obtained by culturing | 02-25-2016 |
20160058806 | METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH - The present invention relates to methods for feeding and stimulating the health of infants delivered via caesarean section comprising administering long chain polyunsaturated fatty acids and/or nucleotides. | 03-03-2016 |
20160081350 | A NEW BACTERIAL LYSOBACTER CAPSICI STRAIN AND USES THEREOF - The present invention relates to a novel bacterial strain belonging to | 03-24-2016 |
20160082054 | SYNBIOTIC COMPOSITION FOR INFANTS - There is provided a preparation comprising | 03-24-2016 |
20160100618 | METHOD FOR STIMULATING THE INTESTINAL FLORA - The present invention relates to methods for feeding and to compositions to be administered to infants delivered via caesarian section and in particular to the use of a) at least two different microorganisms; or b) at least one microorganism and at least one indigestible oligosaccharide; or c)at least two different | 04-14-2016 |
20160106695 | PETROSELINIC ACID OR A COMBINATION OF ACTIVE INGREDIENTS COMPRISING AT LEAST PETROSELINIC ACID FOR PROMOTING WEIGHT LOSS AND/OR WEIGHT MAINTENANCE - The present invention relates to the field of weight management and obesity. It concerns petroselinic acid or a combination of active ingredients including at least petroselinic acid and at least one compound chosen from zinc, taurine, one of the salts of same, lycopene and the mixtures thereof, and preferably at least taurine or zinc gluconate and, more preferably still, at least taurine and zinc gluconate, as a drug for oral administration or as a functional food intended to promote weight loss and/or weight maintenance in a human being and/or animal, or indeed intended to fight obesity. | 04-21-2016 |
20160106793 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM - The subject of the invention is a composition comprising at least a mixture of molecules obtained at least from:
| 04-21-2016 |
20160120915 | METHODS FOR MANIPULATING IMMUNE RESPONSES BY ALTERING MICROBIOTA - The present invention relates to characterizing changes in mammalian microbiota associated with antibiotic treatments and various immunological conditions and related therapeutic methods. Therapeutic methods of the invention involve the use of probiotics, prebiotics, synbiotics, and antibiotics. | 05-05-2016 |
20160120979 | METHOD OF APPLYING A COMPOSITION AND PHARMACEUTICAL COMPOSITION WITH A REGIMEN OF ADMINISTERING IT - A method applying a composition to a human or non-human individual or to an object or a surface area and a pharmaceutical composition with a regimen of administering it to a human or non-human individual is provided. The composition includes an active chemical component for killing of or retarding proliferation of target cells including pathogens, infected cells and cancer cells. The application of the composition and the regimen of administration of the composition are accompanied by at least one exposure to electromagnetic radiation in a range of wavelengths in which the active chemical component absorbs and which has a lower limit of 190 nm, thereby photo-activating the active component. | 05-05-2016 |
20160128339 | CHROMOBACTERIUM FORMULATIONS, COMPOSITIONS, METABLOITES AND THEIR USES - Stabilized biological pesticides comprising | 05-12-2016 |
20160128921 | COMPOSITION COMPRISING A BUFFERED LACTIC ACID - A composition including a buffered lactic acid having a pH within the range of from 3.0 to 6.5 is disclosed. The composition is a lubricant composition and has a water activity of from 0.03 to 0.60. The friction between the absorbent product and the skin/mucous membrane of the user is reduced when in contact with the skin or mucous membrane of the user. An additional advantage is that the composition has a pH in the acidic range which is close to the pH of the skin and/or mucous membrane. | 05-12-2016 |
20160129053 | METHODS OF ISOLATING MICROORGANISMS AND USES THEREOF - Provided herein are methods for preparing a microbiome sample for transplantation into a subject in need thereof. In particular, the methods and compositions relate to methods of repopulating the the microbiome of a subject in the treatment of gastrointestinal maladies e.g., diarrhea and/or constipation. | 05-12-2016 |
20160129055 | PROBIOTIC BIFIDOBACTERIUM LONGUM - Regarding Deposited Microbial Organisms [EXPERT SOLUTION] | 05-12-2016 |
20160136210 | SYNBIOTIC COMPOSITION FOR TREATMENT OF INFECTIONS IN ALLERGIC PATIENTS - The invention concerns the use of prebiotics and probitics for the treatment of infections in allergic patients. | 05-19-2016 |
20160139123 | Shear Wave Imaging Method and Installation for Collecting Information on a Soft Solid - The invention relates to methods comprising a step consisting of determining the proportion and/or the level of T regulatory lymphocytes with a CD4 | 05-19-2016 |
20160143963 | NOVEL STRAIN OF BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND USE THEREOF FOR THE TREATMENT AND/OR PREVENTION OF EXCESS WEIGHT AND OBESITY AND ASSOCIATED DISEASES - The invention is applicable within the food and pharmaceutical industry. More specifically, it relates to a novel strain of the species | 05-26-2016 |
20160144041 | CARRIER FOR DELIVERY OF SUBSTANCE TO PHAGOCYTES - An object of the present invention is to provide a low-cost and safe approach to efficient delivery of a substance to phagocytes. In particular, the present invention relates to a carrier for delivery of a substance to phagocytes, the carrier comprising a lactic acid bacterium and/or an extract thereof. | 05-26-2016 |
20160151408 | NOVEL THERAPY FOR MULTIPLE SCLEROSIS USING VITAMIN D AND GUT BACTERIA | 06-02-2016 |
20160151427 | AMMONIA OXIDIZING BACTERIA FOR TREATMENT OF ACNE | 06-02-2016 |
20160151428 | COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM | 06-02-2016 |
20160166621 | NON-CHEMOTHERAPEUTIC ANTIBIOTIC TREATMENT FOR INFECTIONS IN CATTLE | 06-16-2016 |
20160193257 | HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 07-07-2016 |
20160193284 | USE OF A BACTERIUM ISOLATED FROM THE GENUS PSEUDOALTEROMONAS, CYCLOLIPOPEPTIDES AND USES THEREOF | 07-07-2016 |
20160199337 | Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto | 07-14-2016 |
20160199423 | Compositions and Methods | 07-14-2016 |
20160250239 | FEED SUPPLEMENT COMPRISING OLIGOSACCHARIDES AND MEDIUM CHAIN FATTY ACIDS | 09-01-2016 |
20160375065 | PROBIOTIC THERAPIES FOR AUTISM - Provided is a method and a composition for improving behavioral performance in an individual comprising identifying an individual in need of treatment, and providing such an individual a composition comprising bacteria within the genus | 12-29-2016 |
20180021278 | TREATMENT OR PREVENTION OF INFLAMMATION USING SERINE | 01-25-2018 |
20180021387 | PROBIOTIC COMPOSITIONS AND METHODS OF USE | 01-25-2018 |
20180021390 | PREVOTELLA HISTICOLA PREPARATIONS AND THE TREATMENT OF AUTOIMMUNE CONDITIONS | 01-25-2018 |
20190142873 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 05-16-2019 |
20190142874 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 05-16-2019 |
20190142875 | MICROBIOME-BASED DIAGNOSIS, PREDICTION AND TREATMENT OF RELAPSING OBESITY | 05-16-2019 |
20190142880 | THE USE OF PHYCOCYANINS, PURIFIED OR AS PRESENT IN CYANOBACTERIAL MICROALGAE OR EXTRACTS THEREOF, AS PREBIOTICS, TO ENHANCE THE VIABILITY, GASTROINTESTINAL SURVIVAL, PATHOGEN-FIGHTING ABILITY, AND THE OVERALL HEALTH-ENHANCING PROPERTIES OF PROBIOTIC CULTURES AND PRODUCTS. | 05-16-2019 |
20220133811 | AKKERMANSIA MUCINIPHILA EB-AMDK27 STRAIN AND USE THEREOF - Disclosed are a novel | 05-05-2022 |
20220133817 | Recombinant Bacteria And Uses Thereof - The present disclosure provides a recombinant, probiotic lactic acid bacterium, wherein the bacterium comprises a non-replicating plasmid vector comprising (a) a tumor suppressor gene or anti-inflammatory gene operably linked to a first promoter that directs expression of the tumor suppressor gene or anti-inflammatory gene in a mammalian cell, and (b) an adhesin gene operably linked to a second promoter that directs expression of the adhesin gene in the bacterium. The present disclosure also provides uses of the recombinant bacterium, and methods of constructing the recombinant bacterium. The present disclosure also provides a method of treating cancer in a subject, wherein the method comprises administering a pharmaceutically effective amount of a recombinant, probiotic lactic acid bacterium, wherein the bacterium comprises a non-replicating plasmid vector comprising an adhesin gene operably linked to a promoter that directs expression of the adhesin gene in the bacterium. | 05-05-2022 |